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 Through the lens of Everett Rogers’ Diffusion of Innovations, specifically the 
theory of Perceived Attributes, this dissertation firstly examines key factors leading to or 
deterring adoption of direct-to-consumer genetic testing (DTC-GT) for health 
information through qualitative interviews with prospective customers. Results indicate 
that the main motivations include finding out perceived beneficial health information and 
comparisons to testing via medical providers. The main deterrents for adoption were 
reported to be privacy concerns, perceived susceptibility to conditions, and the desire to 
remain uncertain about one’s genetic health risk. 
Additionally, this dissertation considered the role of issue-specific media framing 
on adoption intent. A second study consisting of an experiment used media framing 
theory to determine which factors would lead to a higher likelihood of adoption. Results 
revealed that media framed to discuss the perceived advantages of the technology had the 
highest likelihood of adoption. Implications for theory and industry are discussed 
throughout this dissertation.  
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CHAPTER I: INTRODUCTION 
In recent years, there has been a technology-enabled shift in consumer health 
innovations, specifically with the accessibility of digital health tools and platforms 
(HCCI, 2019; Healthcare Information and Management Systems Society [HIMSS], 
2019). Recent research in healthcare found that patients are increasingly demanding a 
more efficient health system, and 80% of patients would switch healthcare providers 
solely based on convenience factors (HCCI, 2019). This industry of digital health tools 
seeks to improve the overall patient experience by increasing access to healthcare, 
narrowing gaps in healthcare, and striving for efficiency in health information-seeking 
(HCCI, 2019; Suennen, 2018). Digital consumer health innovations have proposed 
solutions to increasing efficiency of healthcare and lowering barriers to access to 
personalized health information through online platforms. Healthcare trend reports 
propose that the coming years will lead to even more developments and refinements in 
digital health, including virtual healthcare, on-demand health services, artificial 
intelligence powered clinical support, and, one of the most popular trends: direct-to-
consumer services (HIMSS, 2019). One direct-to-consumer health innovation that has 
gained momentum and popularity is direct-to-consumer genetic testing (DTC-GT) for 
health information (HIMSS, 2019; Medium, 2018; Suennen, 2018). DTC-GT as a 
consumer health tool provides information on an individual’s health, including genetic 
health risk assessments, carrier status, and cancer predispositions. These tests can be 
purchased online, without physician referral for testing or having to go through another 




indicating their potential risk for various health conditions. Companies such as 23andMe 
and AncestryHealth offer DNA tests for customers to access personalized health 
information. These testing services are seen as part of the shift in consumer healthcare 
and the attempts at “democratization of medicine” (Suennen, 2018). 
While this technological shift towards digital consumer health solutions proposes 
increased access to healthcare and efficiency of receiving health information, little 
research has examined the adoption of these consumer health innovations. To date, there 
is no theoretically driven framework for analyzing consumer health-related innovations 
specifically. This gap potentially prevents further understanding of which factors would 
lead individuals to be more likely to adopt these consumer health innovations or which 
content is most important for leading to adoption intent. The current study seeks to 
address this gap in the literature by proposing and testing a framework for analysis of 
consumer health-related innovations based on previous technological adoption literature 
and theory, specifically Everett Rogers’ Theory of Perceived Attributes (TPA). TPA is 
part of Rogers’ broader theory, Diffusion of Innovations (DOI), which seeks to 
understand how an innovation diffuses throughout a population or social system (Rogers, 
2003). TPA specifically retains focus on the attributes of a technology, and states that an 
innovation will undergo higher diffusion rates if potential adopters perceive the 
innovation to meet the following five attributes: Relative Advantage, Compatibility, 
Complexity, Trialability, and Observability (Rogers, 2003).  Prior diffusion research has 
found these five attributes to be the most important predictors of technology adoption, as 




While Rogers’ work provides insight into technological adoption as a whole, it 
does not take into account consumer health innovations specifically. Scholars of diffusion 
literature state that each type of technological innovation will have different measures for 
these five attributes, as each innovation could evoke unique needs of Compatibility and 
Relative Advantage, for example (Rogers, 2003). As a result, diffusion scholars 
“encourage the creation of new scale items for each set of innovations” (Rogers, 2003, p. 
211). While there are broad measures currently in place for Rogers’ attributes, they are 
not tailored toward a specific type of innovation (e.g., for Relative Advantage: “This 
innovation has many advantages over the innovation it seeks to replace”). TPA needs 
refinement based on existing literature in health behavioral adoption to see which 
attributes are most important and to modify the scale measures within the context of 
consumer health innovation adoption. 
This dissertation proposes to modify Rogers’ framework within the context of 
consumer health innovations through research of health behavior adoption and related 
fields such as health information-seeking and health privacy preferences. By working to 
create a framework specific to consumer health innovations, this will enable scholars to 
more effectively capture what about a consumer health innovation is seemingly 
incompatible or complex, and if these attributes affect adoption intent within this context. 
Specifically, this dissertation proposes to refine Rogers’ framework by drawing upon 
three communication theories. First, this dissertation will examine literature from 
Communication Privacy Management, which considers factors affecting individuals’ 




2002). Second, literature from the Theory of Motivated Information Management will be 
incorporated, which examines which factors could affect information-seeking or 
avoidance behaviors (Afifi & Weiner, 2006). The third theory used to refine Rogers’ 
model is the Health Belief Model, which argues that specific factors influence an 
individual’s decision to partake in a health-related behavior (Hochbaum, Rosenstock, & 
Kegels, 1952). After an initial literature review of the theoretical frameworks, this 
dissertation will begin its first phase by conducting interviews with a target user 
demographic to identify which factors would be most important to increase adoption 
likelihood or which factors would serve as a barrier to adoption. Altogether, these 
theories and initial interviews will work to build and refine Rogers’ attributes to meet the 
consumer health environment. 
Once Rogers’ attributes are refined for consumer health innovations based on 
relevant literature and user interviews, Study II will test the effectiveness of the proposed 
model through examining the media framing effects of online news articles. Media 
framing refers to the perspective or angle from which a news article is written (De Vreese 
et al., 2001; Goffman, 1974). The common goal of media framing is to encourage or 
discourage certain audience interpretations (De Vreese et al., 2001; Goffman, 1974), such 
as increasing prospective customers’ interest in the adoption of a consumer health 
innovation for example. The rationale for analyzing media framing of online news 
articles is the result of the changing media landscape in which individuals have new 
means to access health information. Scholars state that the current media environment is 




emerging forms of communication mediums and technologies (Chadwick, 2013). 
Examples of traditional media platforms include television and radio, whereas emerging 
media platforms most often refer to online communication platforms such as multimedia 
news sites and social media (Chadwick, 2013). With this rise of communication 
platforms, there has been a shift in how individuals receive, engage with, and are affected 
by health-related information (Fox & Duggan, 2013). Recent work has found that 
individuals are increasingly turning to online resources and offerings to receive health 
information (Beaunoyer et al., 2017; Brossard, 2013; Diaz et al., 2002; Fox & Duggan, 
2013). Approximately 72% of adult Internet users search online for information about 
health-related topics, such as conditions or second opinions on diagnoses (Pew Research 
Center, 2014). Communication scholars have found that changes in accessibility and the 
widespread availability of information have led the Internet to become part of 
individuals’ “health toolkit” (Fox & Duggan, 2013). With regard to the evaluation of 
online health information, over half of online information-seekers claim the Internet is 
equal to or better than counsel from their medical provider (Diaz et al., 2001). 
Additionally, these individuals report not to follow-up with their doctor about online 
health information received (Diaz et al., 2001). With persons perceiving online health 
content as equal to or more valuable than their own doctor, along with not following-up 
on such information, examining additional effects of online health content becomes 
crucial.  
This increase of information online has opened the door to a large number of 




framing effects on adoption intent specifically. Communication researchers utilize 
various framing techniques in their research to understand how some messages may be 
more persuasive than others within different contexts or lead to positive or negative 
sentiment (Gross, 2008; Rodrigue et. al, 2014). However, most of the frames employed in 
research vary greatly from study to study (e.g., episodic vs. thematic, gain vs. loss), and 
may not fully consider the nuances of a consumer health innovation. The goal of this 
dissertation is to propose a framework to analyze health-related innovations from related 
theory research and interviews, and to then test this framework for effectiveness via 
media framing. This information will ideally provide researchers with a framework for 
media framing for consumer health innovations. From an industry perspective, this work 
will help journalists understand how their coverage of health innovations could sway 
interest. Lastly, this could offer communication specialists with a suggested framework 
for communication planning through the identification of the most common adoption 
factors. 
Overall, the research within this dissertation makes two main contributions: 1) it 
will create a tailored framework for analyzing perceptions of consumer health 
innovations based on the refinement of Rogers’ criteria, and 2) it will aim to advance 
media framing literature in terms of the effect of framing consumer health innovations. 
This research aims to shed light on how to analyze the adoption intent of consumer health 
innovations and contribute to the development of two theories: Theory of Perceived 
Attributes and Media Framing. 




two research studies. Chapter II offers an overview of both direct-to-consumer genetic 
testing for health information and genetic testing through a medical provider. Next, 
Chapter III provides an introduction to the theoretical frameworks that will be employed 
within this dissertation’s studies. Chapter IV will detail the initial refinement of Rogers’ 
model based on review of relevant theoretical frameworks and in-depth interviews (Study 
I) with prospective customers. Chapter V discusses the proposed framing effects model 
for reporting on DTC-GT and introduces the research hypotheses for the media framing 
experiment (Study II). Chapter VI will detail the framing experiment and its results. 
Lastly, Chapter VII will cover general research conclusions and recommendations based 






CHAPTER II: BACKGROUND ON GENETIC TESTING THROUGH A 
MEDICAL PROVIDER AND DIRECT-TO-CONSUMER GENETIC TESTING 
The following chapter presents an overview of both direct-to-consumer genetic 
testing for health information and genetic testing through a medical provider. This will 
include an overview of what the typical process entails, timeline for testing, and testing 
output examples for both testing methods. This chapter will also discuss some of the 
main contrasts between the two options that a prospective customer would consider 
before taking a direct-to-consumer test through a company or an in-person test through a 
medical provider. 
 
Genetic Testing for Health Information Through a Medical Provider 
Before the launch of DTC-GT services, individuals seeking health information 
received genetic testing solely through medical providers, such as physicians and genetic 
counselors (Jorde, Carey, & Bamshad, 2015; Uhlman, Schuette, & Yashar, 2009; Veach, 
LeRoy, & Bartels, 2006). This experience of seeking in-person genetic information 
through the guidance of a medical provider differs greatly from DTC-GT services. 
Firstly, genetic testing through a medical provider is typically initiated through physician 
referral and recommendation due to the individual’s personal and family medical history. 
These sessions with a medical provider often incorporate genetic counseling, which is the 
process of “helping people understand and adapt to the medical, psychological, and 
familial implications of genetic contributions to disease” (Uhlman, Schuette, & Yashar, 





● Interpretation of family and medical histories to assess the chance of disease 
occurrence or recurrence. 
● Education about inheritance, testing, management, prevention, resources, and 
research. 
● Counseling to promote informed choices and adaptation to the risk or condition. 
(Uhlman, Schuette, & Yashar, 2009, p. 7).  
Before any type of testing is conducted, the medical provider will conduct an initial 
intake. This intake information begins with an inquiry for the indication of the clinic visit, 
which is what the individual hopes to get out of genetic counseling. Common reasons to 
undergo genetic counseling or initiate genetic testing include the individual’s concerns 
for “assessing future reproductive or personal health risks” (Uhlman, Schuette, & Yashar, 
2009, p. 13). It is not uncommon for the individual to have followed a referral from a 
physician, yet not know why they were recommended for testing or counseling. After this 
initial intake discussion, the medical provider will collect family health history 
information in order to conduct a health risk assessment (Uhlman, Schuette, & Yashar, 
2009; Veach, LeRoy, & Bartels, 2006). The medical provider will work with the 
individual to compose a pedigree chart with information regarding personal and family 
health histories. This pedigree can show patterns of condition inheritance and to what 
extent the individual or their future children may be susceptible. Dependent on the initial 
intake and pedigree, the medical provider will recommend specific genetic tests. The 




experience, looking specifically for conditions based on one’s personal and family health 
history (Uhlman, Schuette, & Yashar, 2009; Veach, LeRoy, & Bartels, 2006). In contrast, 
DTC-GT offers individuals a full panel of results for various conditions without requiring 
any of the users’ personal health information. DTC-GT companies would need to build 
specific tools, such as a family health history pedigree tool, to understand which inherited 
conditions the user might be even more or less susceptible, along with algorithms to 
determine how that would affect one’s genetic health risk (Veach, LeRoy, & Bartels, 
2006). 
Another difference between DTC-GT and testing through a medical provider is 
the necessity of knowing the patient’s background (Uhlman, Schuette, & Yashar, 2009). 
Along with the patients’ health history, it is crucial for medical providers to know their 
patients’ cultural, social, and educational background. Medical providers, especially 
genetic counselors, must be familiar with the background of their patients. This is so the 
provider can practice cultural sensitivity, tailor their communication to best meet the 
patients’ needs, and strive for mutual understanding (Uhlman, Schuette, & Yashar, 2009; 
Veach, LeRoy, & Bartels, 2006). During in-person genetic counseling sessions, there is 
also a continual check of patient understanding; a feedback loop which enables the 
medical provider to modify the session by further explaining topics of inheritance or 
implications of a condition (Uhlman, Schuette, & Yashar, 2009). There is the aspect of 
psychosocial counseling and support involved in each session. As genetic testing can 
provoke feelings of anxiety, uncertainty, and sadness in patients, medical providers 




Schuette, & Yashar, 2009). These providers will look closely at patient body language, 
what they say or omit from conversation, and tone to see how further guidance or support 
can be provided. This interaction between the patient and medical provider is a distinct 
contrast from DTC-GT, which the individual in consumer testing will most often have no 
contact with a medical professional. In DTC-GT, customers do not receive this type of 
support; most companies do not offer counseling for testing or further explanation of test 
implications beyond their standardized medical reports. Overall, genetic testing through a 
medical provider offers a more interactive, personalized testing experience than DTC-
GT. 
 
Direct-to-Consumer Genetic Testing 
Differing from in-person genetic testing via medical providers is direct-to-
consumer genetic testing for health information. DTC-GT has risen in popularity within 
the past years (Medium, 2018, Mintel, 2019). DTC-GT companies offer in vitro 
diagnostic testing, which enables individuals to receive personalized information about 
their health including genetic risk assessments, carrier status, and wellness information 
(FDA, 2019). There are two main approaches to consumer-initiated genetic testing 
services: physician-mediated or direct-to-consumer. In physician-mediated genetic 
testing, after a customer purchases a test from an online company such as Color or Helix, 
the customer’s own physician or a physician affiliated with the testing company must 
review and approve the customer order before the testing process can begin (FDA, 2019). 




Administration (FDA) is not typically required for the company to offer their testing 
services. In direct-to-consumer genetic testing, however, the customer can purchase the 
genetic test and access their results without needing the approval of a physician or other 
intermediary. DTC-GT companies are required to go through the FDA for approval of the 
reliability and validity of testing procedures and report output, along with report 
comprehension levels and whether an individual could understand their results without 
the involvement of a medical provider (FDA, 2019). Some of these direct-to-consumer 
tests follow standards by the Clinical Laboratory Improvement Amendments (CLIA), 
which “cover how tests are performed, the qualifications of laboratory personnel, and 
quality control and testing procedures for each laboratory. By controlling the quality of 
laboratory practices, CLIA standards are designed to ensure the analytical validity of 
genetic tests” (MedlinePlus, 2020). However, not all of the existing DTC-GT providers 
are CLIA-certified (MedlinePlus, 2020). 
The DTC-GT process begins with the user purchasing a DNA kit online from a 
testing company, such as 23andMe. The company sends a DNA kit in the mail to the user 
in order to retrieve a DNA sample for testing, which is most often a saliva sample. The 
user will send their DNA sample to the testing company, which is subsequently analyzed 
in a lab for genetic variants. The testing report output is delivered to the user via the 
company’s online interface, most often in a series of report pages per condition. This 
entire process takes approximately 4–8 weeks, but may take longer due to laboratory or 
mailing delays. 




one’s genetic risks for certain cancers along with other medical conditions and diseases. 
Individuals find out information regarding their genetic risk, and whether it is below, 
above, or average to typical risk levels (FDA, 2019). For cancer predisposition, many 
DTC-GT companies offer testing for variants associated with breast cancer, ovarian 
cancer, uterine cancer, colon cancer, melanoma, pancreatic cancer, and stomach cancer. 
Excluding cancer predisposition, the most commonly included medical conditions these 
DTC-GT services test for include celiac disease, Alzheimer’s disease, Parkinson’s 
disease, hereditary thrombophilia, familial hypercholesterolemia, and macular 
degeneration (23andMe, 2019; Helix, 2019; MyHeritage DNA, 2019). Alongside genetic 
health risk, DTC-GT services offer wellness information. These tests offer information 
regarding one’s lactose intolerance, caffeine metabolism, or reactions to alcohol for 
example. DTC-GT provides this health information through the detection variants in an 
individual’s genome that could potentially cause disease. Variants are defined as a 
change within a DNA sequence (Jorde, Carey, & Bamshad, 2016). These variants could 
be pathogenic and disease-causing, benign with no impact on one’s health, or of 
unknown significance. The DTC-GT services offer testing for both autosomal dominant, 
autosomal recessive, and X-linked conditions. For autosomal dominant conditions, an 
individual would only need a variant in one copy of a gene to have that condition and an 
increased risk of developing an associated disease. In contrast, individuals with 
autosomal recessive conditions must have a variant in both copies of a gene to have the 
condition (MedlinePlus, 2019). X-linked conditions originate from variants in genes 




genetic risks, the testing does not determine one’s overall risk for a disease, which can 
vary greatly by environmental and lifestyle factors (FDA, 2019). 
These genetic tests also offer insight into carrier status, namely if one is a carrier 
for an autosomal recessive condition such as cystic fibrosis, sickle cell anemia, or Tay-
Sachs disease. In autosomal recessive inheritance, an individual must have a variant in 
both copies of a gene to have the associated condition (MedlinePlus, 2019). If an 
individual has a variant in only one copy of a gene, they are a carrier of that condition. 
Carriers of autosomal recessive conditions do not have the condition nor typically display 
symptoms of the condition. For example, a carrier of cystic fibrosis will not typically 
have a compromised upper respiratory tract. This carrier information provides insight into 
which conditions the individual may pass on to their child or children. For instance, if 
both parents are carriers for a condition such as cystic fibrosis, each child will have a 
25% of being born with the condition (CHOP, 2018). Some carrier tests look at X-linked 
conditions, such as red-green color blindness and Hemophilia A (CHOP, 2018). X-linked 
conditions are caused by variants in genes on the X chromosome. Women with one 
variant in a gene on the X chromosome are likely to be carriers of an X-linked recessive 
condition rather than being affected with the condition. This is because most women have 
two copies of the X chromosome, and the effect of a variant on one X chromosome can 
be offset by the normal gene on the other X chromosome. As most men only have one X 
chromosome, they are likely to have an X-linked recessive condition if they have a 
variant on that chromosome. These carrier status test results are most often used to 




individuals with testing results for a variety of conditions, in addition to access to tailored 






CHAPTER III: THEORETICAL FRAMEWORKS 
The following chapter provides an overview of the theoretical frameworks for this 
dissertation, in addition to past literature this research seeks to build upon. The 
overarching framework for this dissertation is Everett Rogers’ Theory of Perceived 
Attributes, from his broader Diffusion of Innovations work, specifically examining which 
factors will lead to a higher intent to adopt a new technology. This chapter also includes 
relevant literature from Communication Privacy Management, the Theory of Motivated 
Information Management, and the Health Belief Model that will be used in an attempt to 
refine Rogers’ Perceived Attributes to be more applicable to the consumer health 
innovation environment. After gaining insight into a refined model, research questions 
will be posed to investigate in Study I. This chapter also covers Media Framing which 
will be used in Study II to test the proposed and refined adoption model from Study I. 
While the goal of the research is not to imply nor investigate causation, the work will be 
used to inform a proposed and tailored adoption framework for consumer health 
innovations, including possible motivations and barriers to engagement. The following 
review of literature will detail these theories and concepts in further depth. 
 
Diffusion of Innovations and Theory of Perceived Attributes 
While there is limited research examining the likelihood of adopting DTC-GT and 
other emerging consumer health innovations, there are numerous articles pertaining to the 
evaluation of technology broadly and innovations for healthcare providers and health 




innovations. Research on the adoption cycle of new technologies is strongly rooted in 
Everett Rogers' Diffusion of Innovations (DOI) and the context of Perceived Attributes. 
DOI seeks to explain how an innovation diffuses throughout a population or social 
system. Diffusion is the process by which an “innovation is communicated through 
certain channels over time among the members of a social system” (Rogers, 2003, p. 26). 
DOI defines an innovation as an object, idea, or practice that is perceived to be new by an 
individual or group (Rogers, 2003). It is important to note that even if a technology has 
been around for a long period of time, it will still be labeled an “innovation” if the 
potential adopter perceives the innovation to be new (Rogers, 2003, p. 26). The span of 
innovation types ranges broadly from tangible objects such as technologies to ideological 
ways of thinking. Diffusion studies focus on the rate of adoption of innovations, which 
occurs when an individual makes the decision to fully use the innovation (Rogers, 2003). 
Diffusion research has found that the adoption rate of innovations is not 
simultaneous across populations (Rogers, 2003). Scholars argue that specific groups of 
individuals may be more or less likely to adopt technology. There are five distinct 
adopter categories commonly referenced in diffusion literature: innovators, early 
adopters, early majority, late majority, and laggards (Rogers, 2003). These five categories 
of adopters will accept and use new forms of technologies at different times, as based on 





Figure 1. Adoption/Innovation Curve (Rogers, 2003) 
The first category, the innovators, are among the first to adopt new forms of 
technology. This 2.5% of the adoption population are eager to test out new ideas and 
innovations. Innovators typically have extensive financial resources and vast knowledge 
of technology and potential technological applications. Innovators are generally seen as 
impulsive risk-takers by their peers (Rogers, 2003). The following wave of adopters is 
known as the early adopters, 13.5% of the population. This category of adopters is 
interested in testing the latest forms of technology, but not quite as trend-driven as the 
innovators group (Rogers, 2003). The next wave includes the early majority of the 
population, 34% of adopters. This type of adopter will employ new forms of technology 
just before the general majority, but will take a longer time to decide before committing 
to adopt a new technology. The fourth category is the late majority. These adopters, 
encompassing 34% of the population, will employ new technologies only after the 




to adopt new technologies until they face pressure from their peers (Rogers, 2003). The 
last wave of adopters is referred to as laggards and occupy 16% of all adopters. Laggards 
are suspicious of new technologies and prefer to utilize older, traditional devices (Rogers, 
2003). Past diffusion research has found that most of the general population falls into the 
middle categories of adopters (Rogers, 2003). From DOI’s classification of adopters, 
widespread diffusion of new technologies is not instantaneous; adoption of innovative 
devices will take time due to the distinct adopter categories and preferences.  
In addition to adopter categories, other factors affecting adoption of an innovation 
include the perceived attributes of an innovation (Rogers, 2003), which is what the 
current study proposes to refine within the context of consumer health innovations. 
Rogers’ Theory of Perceived Attributes argues that, if an innovation is perceived to meet 
five specific attributes, there will be a higher likelihood of adoption (Rogers, 2003). In 
TPA, it is argued that potential adopters judge innovations based on five distinct 
attributes: Relative Advantage, Compatibility, Complexity, Trialability, and 
Observability. While TPA is a part of the diffusion process and broader DOI theory, 
Rogers states that perceived attributes are often researched as a separate study to “predict 
the rate of adoption” (Rogers, 2003, p. 248). Additionally, DOI has found these five 
attributes to be the most important predictors of technology adoption, as they explain up 
to 87% of the variance in adoption (Rogers, 2003). 
The first listed attribute, Relative Advantage, refers to the extent that the 
innovation is seen to be better than what it supersedes (Rogers, 2003). This attribute 




scholars state that potential adopters need to know the degree to which a new innovation 
is an improvement over the existing technology familiar to the individual (Rogers, 2003). 
Components of Relative Advantage include “economic profitability, low initial cost, a 
decrease in discomfort, social prestige, a saving of time and effort, and immediacy of 
reward” (Rogers, 2003, p. 219). Scholarship has found that Relative Advantage is one of 
the strongest predictors to affect the likelihood of adopting an innovation in any field 
(Rogers, 2003). 
The second attribute, Compatibility, examines how the innovation is consistent or 
contrasts the values, needs, preferences, or experiences of potential adopters (Rogers, 
2003). An innovation with Compatibility will be less uncertain to the potential adopter 
and align closely with the potential adopter’s life situation and values. An integral 
component of Compatibility is cultural compatibility; if the innovation conflicts with 
cultural norms, such as ideologies, it will be less likely to be adopted. Along with 
Relative Advantage, Compatibility is seen as a strong predictor of innovation adoption 
(Rogers, 2003).  
Complexity refers to how difficult the innovation is to either understand, engage 
with, or use (Rogers, 2003). Examples of complex innovations include those which need 
extensive training before use or another type of tutorial. In contrast, innovations with less 
Complexity are intuitive and easy to understand. The more difficult or seemingly 
complex an innovation is, the less likely it will undergo widespread diffusion (Berwick, 
2003; Rogers, 2003).   




otherwise tested before committing to adoption (Rogers, 2003). The more Trialability an 
innovation is perceived to have, the more likely it will have higher diffusion rates and a 
likelihood to adopt (Rogers, 2003).  
Lastly, Rogers states that Observability is another factor which can impact 
adoption. Observability is the extent to which the innovation provides results that are 
tangible (Rogers, 2003). If an individual is able to see the results from an innovation, 
such as a DNA testing result output or how the results may impact their health, it will be 
more likely to undergo diffusion.  
Although Rogers' theory provides a conceptual framework for technology 
adoption, it does not take into account the different contexts in which a technology is 
introduced. It is uncertain whether Rogers’ criteria are enough to foresee adoption for 
consumer health innovations such as DTC-GT. With regard to adoption of health 
technology specifically, studies have focused on the adoption of health technology by 
hospitals or medical providers, not consumer-focused applications. Within a health 
provider context specifically, the most common attributes associated with adoption intent 
include Compatibility, specifically privacy standards, and Observability, waiting for the 
technology to be proven successful (Berwick, 2003; Coleman et al., 1966, Ford, 2006; 
Gabbay & le May, 2004; Muensterer et al., 2014). Although there are differences 
between medical providers and consumers, this literature may provide insight into how 
consumer health innovations are viewed. Literature examining health technology 
adoption has largely found that adopters of medical technology have been portrayed as 




whole tend to be slow in comparison to other types of innovations (Berwick, 2003). Part 
of this slow diffusion process relates to individuals waiting for a health technology to be 
proven effective before adoption (Ford, 2006). Because of the high-stakes medical 
environment, medical providers must have the reassurance that a technology is reliable 
and sound before they can commit to adoption (Coleman et al., 1966). Within the case of 
adopting a medical device for a clinical practice, medical providers rely on their peers' 
past experiences and information pertaining to new technologies (Gabbay & le May, 
2004). As argued in the literature, medical providers ultimately wait for technology to be 
proven effective before incorporating a new technology device into their practice. In 
short, the health technology must have tangible and observable results prior to adoption. 
This relates to TPA and shows that Observability is an important criterion within the 
context of health technology adoption by medical practitioners.  
Another factor found to impact medical technology adoption is Compatibility, 
specifically with data protection and security (Muensterer et al., 2014). As mandated by 
law, doctors must comply with the Health Insurance Portability and Accountability Act 
(HIPAA), which states that all individually identifiable health information documents 
must be protected (HHS, 2015). If a health technology did not have data protection 
software, or if the device transmitted data to an unencrypted server, the device would not 
be adopted for risk of publicizing patient records and information (Muensterer et al., 
2014).  
While the studies discussed above within this chapter may not directly relate to 




Rogers’ criteria are of important consideration. From the aforementioned literature, it is 
evident that the adopter category and perceived attributes of an innovation, specifically 
Relative advantage, Observability, and Compatibility, will have an impact on the 
likelihood of adopting an innovation.  
 
Health Behavior Engagement and Related Theories 
In addition to Rogers’ Diffusion of Innovations and Theory of Perceived 
Attributes, health-related communication theories can also shed insight into what may 
increase an individual’s intent to partake in a health-related behavior. This section will 
detail information from related theories including health behavior, information-seeking, 
and privacy management, which will be used to begin to refine Rogers’ Perceived 
Attributes for the consumer health innovation environment. The main theoretical 
frameworks that will be examined in this section are Communication Privacy 
Management, Theory of Motivated Information Management, and the Health Belief 
Model. The following literature will be used to prepare for Study I specifically, which 
consists of interviews with prospective DTC-GT customers, probing on their main 
motivations or barriers for taking a health test. 
 
Theory of Motivated Information Management 
Rogers’ TPA states that if a technology is seen to meet users’ needs, beliefs, and 
values, it will be more likely to undergo adoption (Rogers, 2003). As consumer health 




related to users’ needs regarding health information seeking, avoidance, and 
management. One often-employed theory is the Theory of Motivated Information 
Management (TMIM), which seeks to understand different factors which could affect 
information-management behaviors such as information-seeking or avoidance. The 
TMIM proposes that the process of information-management is represented generally by 
three phases: interpretation, evaluation, and decision. The interpretation phase begins 
when an individual becomes aware of a situation in which they desire more or less 
uncertainty (Afifi & Weiner, 2006). This “mismatch” between current uncertainty and 
desired uncertainty levels is known as an uncertainty discrepancy (UCD). An example for 
direct-to-consumer genetic testing could be an individual stating uncertainty over whether 
they have a gene for an increased risk of breast cancer. The UCD has been shown to lead 
to an increase in anxiety levels (Afifi & Weiner, 2006, p. 175). In order to mitigate and 
manage this reaction of anxiety, the information-seeking or avoidance processes begin 
(Afifi & Weiner, 2006). 
The second phase of TMIM, the evaluation phase, occurs when the individual 
reflects on expectations and perceived outcomes of the information-seeking and 
perceived ability to engage in decisions associated with that decision (Afifi & Weiner, 
2006). This phase consists of two main sets of perceptions: outcome assessments and 
efficacy assessments. Outcome assessments include the expected outcomes that the 
information search may produce. The two outcome assessments are outcome importance 
(OI) and outcome probability (OP) (Afifi & Weiner, 2006). Outcome importance is 




probability is the perceived likelihood that the information-seeking will result in the 
expected outcome (e.g., information retrieval). Relating back to the example of the 
individual uncertain over their risk for breast cancer, outcome importance is the extent 
that the individual considers knowing this cancer risk important. For outcome probability, 
this entails the extent that taking the direct-to-consumer test will likely lead to the 
specific breast cancer risk assessment. In addition to outcome assessments, the individual 
considers efficacy assessments, which include the extent that the individual perceives 
himself or herself as able to reduce the UCD through information-seeking behavior. The 
first efficacy assessment is coping efficacy, which is the individual's belief that they have 
the emotional, social, and instrumental resources to manage and process the information 
they receive (Afifi & Weiner, 2006). For the individual contemplating direct-to-consumer 
testing for breast cancer, coping efficacy would revolve around whether they felt able to 
handle a potentially positive testing result indicating a higher susceptibility of breast 
cancer. The next assessment is communication efficacy, which is defined as the 
individual’s perception that they have the skills needed to successfully complete the 
communication tasks involved in the information-management process (e.g. talking to 
someone to solicit information about the topic in question) (Afifi & Weiner, 2006). For 
the direct-to-consumer genetic testing example, communication efficacy would 
encompass the individual’s perceived ability to interpret their testing result output. 
Lastly, there are the target efficacy and target honesty assessments. Together, these 
assessments take into account whether the individual believes the potential information 




Weiner, 2006). For direct-to-consumer testing, the testing service is the “target.” The 
individual would evaluate the trustworthiness and validity of the testing service for the 
target assessments. 
The last stage is the decision phase, which involves the selection of the desired 
information-management strategy to address the UCD. The individual at this stage can 
choose to pursue the information-seeking actions, avoid relevant information, or change 
the way they think about the situation in question (Afifi & Weiner, 2006). If the 
individual decides to seek relevant information, there are three general categories of 
information-seeking actions: passive strategies, active strategies, and interactive 
strategies (Berger & Kellman, 1994). Passive strategies for information-seeking involve 
unobtrusive measures such as observation of the information provider’s behavior. Active 
strategies are more direct and entail asking third parties for information about the 
information provider or manipulating an environment to examine the target’s response. 
Interactive strategies, which are most common within the case of health information 
seeking, involve direct interactions with the information-provider, such as an in-person 
conversation (Berger & Kellman, 1994). For direct-to-consumer testing, the individual 
would go through an interactive communication strategy, as they would have to initiate 
the purchase of the test and submit a DNA sample. 
Instead of seeking out information, the individual will sometimes avoid relevant 
information completely, dependent on the context of the information-seeking. Other 
times, the individual may go through a cognitive reappraisal process which manages the 




changing how important they perceive the issue to be, the gravity of the situation, or their 
desired level of uncertainty (Afifi & Weiner, 2006). Some individuals partake in 
cognitive reappraisal through downward social comparison and self-reflection via 
comparison to others (Festinger, 1964). In downward social comparison, an individual 
will turn to another individual or group that they consider to be worse-off than 
themselves in order to feel better or more content about their own situation (“They have 
got it much worse, therefore I feel better about myself”). This type of social comparison 
has been shown to result in a more positive mood by the comparer (Festinger, 1964). In 
the case of cognitive reappraisal, anxiety from the UCD diminished as a component of 
altering the need for uncertainty management, not reducing uncertainty through 
information gathering. For the direct-to-consumer example, the individual would alter 
their way of thinking by convincing themselves they could be of low risk for breast 
cancer or stating it may not be as severe of a cancer as other forms, for example. 
 
Information-seeking and avoidance in a health context 
With regards to information-seeking behavior in health literature, prior research 
has shown high levels of uncertainty, communication efficacy, and positive outcome 
probability to be factors in health information-seeking behavior (Afifi & Afifi, 2009; 
Afifi et al., 2006; Afifi & Weiner, 2006; Hovick, 2014; Su, Howard, & Borry, 2011). For 
positive outcome probability, a study examining individuals’ willingness to seek out 
sexual health information from their partners found that participants were willing to 




positive response from that partner (Afifi & Weiner, 2006). Another study examining the 
decision to talk about organ donation with family members found that participants were 
more likely to discuss organ donation if they felt they had high communication efficacy 
and the ability to discuss these topics with their family (Afifi et al., 2006). Conversely, 
low outcome expectancies resulted in information avoidance behavior (Afifi & Afifi, 
2009; Afifi et al., 2006; Afifi & Weiner, 2006; Hovick, 2014). 
While uncertainty may lead individuals to seek out relevant health information, it 
is relatively common for persons to specifically avoid health information to maintain 
uncertainty (Barbour, Rintamaki, Ramsey, & Brashers; 2012; Sairanen & Savolainen, 
2010). Research has found that individuals may experience health-related uncertainty as a 
positive state for avoiding anxiety or potentially uncomfortable news (Fanos & Johnson, 
1995; Lerman et al., 1999). A study on individuals with a hereditary risk of colon cancer 
found that approximately 60% of respondents declined the offer of genetic confirmatory 
testing (Lerman et al., 1999). In these cases, elevated levels of uncertainty may produce 
levels of hope or optimism in individuals, specifically in potentially negative health 
scenarios such as severe diagnoses or mortality (Davis, 1960).  
The aforementioned literature sheds light on the possible tensions of seeking out 
or avoiding specific types of information. As consumer health innovations provide users 
with health information, it is important to first examine literature pertaining to 
individuals’ behavior regarding health information seeking or avoidance. Concepts from 
TMIM and health information-seeking studies have found that one’s desire for 




This suggests that, if an individual would rather not know they are at risk, they would 
have a higher desire for uncertainty and therefore be less likely to seek-out information 
provided from a consumer health innovation. This idea of desire for uncertainty will be 
further examined during the interviews in Study I, and in turn used to begin refining 
Rogers’ model for the consumer health innovation environment. 
 
Communication Privacy Management 
Another factor which could potentially affect the likelihood of adopting a 
consumer health innovation is an individual’s privacy preferences, which also ties into 
Rogers’ Compatibility attribute. Prior research has found that one’s privacy preferences 
can affect the likelihood of adopting a health technology, sharing health information, and 
partaking in a health-related behavior (Geer et al., 2001; Petronio & Altman, 2002; Siani 
& Assaraf, 2016; Veach, LeRoy, & Bartels, 2006). The Theory of Communication 
Privacy Management (CPM) specifically examines the potential barriers to disclosing or 
concealing information individuals deem private. In CPM, scholars argue that individuals 
consider private information to be something they own and have ownership (Petronio & 
Altman, 2002). When an individual decides to share something private with another, that 
recipient becomes a co-owner of this private information. It is crucial to note that the co-
owners are not full owners of the private information shared with them; if a co-owner 
were to discuss the information shared with another person, they would be in violation of 





CPM states that all individuals have privacy boundaries which have varying 
permeability levels that in turn affect information disclosure around certain topics. These 
boundaries can be very thick, indicating a lower likelihood of disclosing and risky 
information, or very thin and permeable, indicating a higher likelihood to disclose and 
not as risky information. Health information is generally considered sensitive and 
confidential information (Petronio & Altman, 2002; Veach, LeRoy, & Bartels, 2006). As 
a result, scholars have found individuals to be less likely to disclose health information at 
is potentially “higher risk” than something such as one’s favorite color or food (Petronio 
& Altman, 2002). 
Research has also discussed the potential repercussions of individuals sharing 
health-related data, specifically in regard to repercussions of others’ accessing their 
genetic information. One of the feared consequences of sharing health data is genetic 
discrimination (Godard et al., 2004; Uhlman, Schuette, & Yashar, 2009; Williams et al., 
1999). Genetic discrimination occurs when individuals are treated unjustly, differently, or 
unfairly because they have a gene that causes or increases the risk of developing an 
inherited condition (Genome, 2017; NIH, 2019). Examples of genetic discrimination 
could be 1) an insurance company denying an individual coverage for a pre-existing 
health condition found within direct-to-consumer testing, or 2) requiring higher insurance 
premiums based on health testing information (NIH, 2019). 
There are many United States laws in place to help protect individuals from 
genetic discrimination, such as the Genetic Information Nondiscrimination Act (GINA) 




and makes it illegal for health insurance providers to deny coverage or enforce higher 
premiums based on a person’s genetic information (Genome, 2017; NIH, 2019). Title II 
prohibits and makes it illegal for employers to use an individual’s genetic information to 
guide employment decisions (Genome, 2017; NIH, 2019). Although this act currently 
states protection for nondiscrimination based on genetics, there is no assurance this law 
will remain the same in future years, or if it will have exceptions for certain conditions 
(FDA, 2019). Despite these laws and large-scale efforts to protect persons from genetic 
discrimination, there is still hesitation to take a genetic test due to privacy by potential 
adopters (NIH, 2019). 
Altogether, the aforementioned literature details how privacy boundaries and 
perceived repercussions of sharing health data can deter an individual from sharing 
health-related information (Geer et al., 2001; Petronio & Altman, 2002; Siani & Assaraf, 
2016; Veach, LeRoy, & Bartels, 2006). This suggests the refinement of Rogers’ 
Compatibility attribute; that individuals’ privacy needs may be a factor affecting adoption 
intent. This literature also indicates that individuals will have varying levels of privacy 
boundaries, and that for individuals with thicker privacy boundaries, those more 
concerned with privacy, they will be even less likely to adopt a consumer health 
innovation. Study I will examine the concept of health-related privacy in further detail 
during the prospective user interviews, to see how pervasive privacy concerns may be 
within this consumer health environment. Those interview results will be used to further 





Health Belief Model 
 When looking to refine Rogers’ model within a health context, it is important to 
examine literature regarding health-behavior and engagement. Scholars have noted that 
five factors that can influence an individual’s decision to partake in a health-related 
behavior specifically. These factors, together known as the Health Belief Model, include 
the following six components: perceived susceptibility, perceived severity, perceived 
benefits, perceived barriers, cue to action, and self-efficacy (Hochbaum, Rosenstock, & 
Kegels, 1952). Perceived susceptibility refers to the individual’s perception of their risk 
of acquiring an illness, disease, or condition.  Perceived severity is the extent to which a 
person believes the condition, disease, or illness of mention is serious or harmful. 
Perceived benefits refer to the person’s belief that the specific action will result in 
positive outcomes. Perceived barriers are the individual’s perceived negative attributes 
associated with the health-related action. Cue to action refers to what prompts the 
individual to take action and can be internal or external. Lastly, self-efficacy is the extent 
to which an individual perceives himself or herself as capable to perform a specific health 
behavior. In regards to literature regarding motivations or barriers to partaking in health-
related tests and screenings, research has focused predominantly on in-person cancer 
screenings for conditions such as colorectal and breast cancer (Cyr, Dunnagan, & 
Haynes, 2010; Darvishpour, Vajari, & Noroozi, 2018; Masoudiyekta, Dashtbozorgi, 
Gheibizadeh, Malehi, & Moradi, 2015). While the HBM has been applied in myriad 
health-related studies, research has found that the influence of these factors can vary 




for breast cancers (Darvishpour, Vajari, & Noroozi, 2018), it was found that perceived 
benefits, self-efficacy, and perceived barriers were the highest predictors of completing 
self-exams for breast cancer. Within the context of sexual health, individuals with fewer 
perceived barriers (e.g., cost of contraception, negative attitudes toward condoms) were 
more likely to employ effective contraceptive practices, while other factors in the HBM 
had little impact (Lowe & Radius, 1987). For the use of tobacco, perceived susceptibility 
to smoking-related disease strongly correlated with lower levels of tobacco use for 
smokers and non-smokers (Li et al., 2003). Perceived severity and self-efficacy were 
strong predictors of healthy eating in college students (Deshpande et al., 2009). 
In the aforementioned literature, some factors of the HBM were found to be 
significant, whereas others were not found to have a significant effect on the specific 
health behavior. The inconsistency of each variable’s strength across varying contexts 
leads to increased questioning for how these factors could be applied to the context of 
consumer health innovations, and which factors would have the most weight in the 
decision to adopt this type of technology. Study I will attempt to narrow down which 
factors have the most strength or even affect the intent to adopt a consumer health 
innovation, using DTC-GT as a case study. The results from those interviews will be used 
to further refine Rogers’ model. 
 
Media Framing 
Once Rogers’ Perceived Attributes have been refined from aforementioned 




(see Chapter IV) these attributes will be tested in an experiment that examines media 
framing effects. The reasoning behind this examination of media framing effects stems 
from the changing media environment and how individuals are increasingly turning to 
online resources for health information (Beaunoyer et al., 2017; Brossard, 2013; Diaz et 
al., 2002; Fox & Duggan, 2013). Scholars state that the current media landscape is within 
a hybrid media system, one that combines and employs both traditional and emerging 
forms of communication platforms (Brossard, 2013; Chadwick, 2013). Examples of these 
new platforms include online resources such as multimedia news sites or social media 
(Beaunoyer et al., 2017; Chadwick, 2013). With this widespread availability of online 
communication platforms, there has been a shift in how individuals receive, engage with, 
and are affected by health-related information (Beaunoyer et al., 2017; Diaz et al., 2001; 
Fox & Duggan, 2013). Online health-information search rates have increased (Diaz et al., 
2001; Thackerway, Crookston, & West, 2013), and over half of online information-
seekers deemed the Internet to be “same as” or “better than” advice from their own 
doctor, and it is common for individuals not to follow-up with their doctor about online 
health information received (Diaz et al., 2001, p. 182). With individuals interpreting 
online information as equally or more valuable than their medical provider and not 
following-up regarding information found, examining the effects of online health content 
becomes crucial. Furthermore, it is important to understand how individuals interpret and 
respond to this type of online information, as the “online era is characterized by indirect 





In order to measure individuals’ evaluations of health topics or intent to partake in 
a health-related behavior, scholars commonly employ media framing. Health 
communication researchers have used various media framing techniques in their research 
to understand how some communication messages may be more persuasive and credible 
than others within different health contexts, or lead to positive or negative sentiment. 
Framing research is attributed to the work of Erving Goffman, a sociologist who first 
coined framing in his seminal work. Goffman defines a message frame as a “schemata of 
interpretation” that individuals use to understand and make sense of topics or occurrences 
(Goffman, 1974, p. 21).  Prior research has found that news frames, or the way the news 
frames an issue, can positively affect individuals’ thoughts or perceptions on a topic 
(Kozman, 2017; De Vreese et al., 2001; Jackson, 2010; Guenduez, Schedler, & Ciocan, 
2016; Schuk & de Vreese, 2006). While some frames are generic, and cross many fields, 
such as episodic vs. thematic, gain vs. loss, other frames can also be derived from 
literature or issue-specific, as the current study proposes. 
Issue-specific framing pertains to specific topics within the news and highlights in 
great detail varying aspects of a topic or event (Ciocan, 2016; De Vreese et al., 2001; 
Guenduez, Schedler, & Ciocan, 2016). Issue-specific frames capture “specific aspects of 
selection, organization, and elaboration that are present in news coverage and pertains 
specifically to a well-defined issue” (De Vreese et al., 2001, p. 108). This type of frame is 
often used in contrast to types of generic framing, which is more widely applicable to a 
different range of topics or events (Guenduez, Schedler, & Ciocan, 2016). The main 




responsibility, economic consequences, human interest, and morality (Kozman, 2017; De 
Vreese et al., 2001; Guenduez, Schedler, & Ciocan, 2016). In generic-framed studies, 
scholars will often examine how different types of news media portray certain topics 
within the context of the five generic frames (Kozman, 2017; De Vreese et al., 2001; 
Guenduez, Schedler, & Ciocan, 2016). Issue-specific frames are tailored; they vary 
specifically from topic to topic to determine subsequent effects on an audience (De 
Vreese et al., 2001). For example, issue-specific framing for DTC-GT may include 
highlighting or minimizing various factors of the testing, such as 1) its relative advantage 
to in-person genetic testing or 2) addressing the privacy concerns around this technology. 
A generic-framed article on DTC-GT would employ one of the five commonly-studied 
frames, and perhaps analyze the testing through an economic lens or broadly discuss the 
human interest in this technology. Although generic frames are more generalizable in the 
sense they allow for direct comparison between topics, they offer less possibility for 
examining a topic in fine detail and its subsequent effects on an audience (De Vreese et 
al., 2001). 
Within framing literature, there is no consistent frame used within a health 
context to predict the adoption of an innovation or engagement with a health behavior, or 
a benchmark for comparison. Studies have shown that exposure to a media frame is 
generally positively linked to intent to partake in specific behavior or result in overall 
increased levels of persuasiveness (Gross, 2008; Jackson, 2010; Rodrigue et. al, 2014; 
Schuk & de Vreese, 2006). However, most frames employed in research vary greatly 




Kohring, 2008; Scheufele & Tewksbury, 2007), and may not fully consider the specifics 
or nuances of a consumer health innovation. Study II attempts to address this gap by 
creating a media framing approach via issue-specific frames to be measurable and 
available to replicate in future studies for consumer health innovations. For this 
dissertation, which focuses specifically on consumer health-related technology adoption, 
the issue-specific media frames tested will be operationalized using Rogers’ refined 
attributes, which are further discussed in Study I within Chapter IV. The goal of this 
framing study specifically is to build a set of issue-specific frames that can be used to 
examine perceptions of consumer health innovations. In this research, the overarching 
“issue” for this issue-specific framing will be consumer health innovations, using direct-
to-consumer genetic testing as a case study. As a way of identifying issue-specific frames 
to employ, this dissertation will draw upon literature from Rogers’ Perceived Attributes, a 
literature review in the field of health communication, and results from in-depth 
interviews with prospective DTC-GT customers (Study I). Each issue-specific frame will 
separately highlight different aspects of DTC-GT to see if exposure to an issue-framed 
article is associated with the participants’ likelihood to adopt DTC-GT.  The upcoming 
chapters will cover 1) Study I’s refinement of Rogers’ Perceived Attributes model for 
DTC-GT based on past literature and user interviews, and 2) testing the refined model 






CHAPTER IV: STUDY I – REFINING ROGERS’ ATTRIBUTES THROUGH 
EXPLORATORY INTERVIEWS WITH A TARGET USER-DEMOGRAPHIC 
Overview and Goals of Study I 
This chapter will discuss the exploratory interviews with prospective DTC-GT 
adopters. The purpose of these interviews was to gain initial insight into which factors 
would lead to a higher likelihood of adoption of direct-to-consumer genetic testing, and 
to refine Rogers’ theory in the consumer health environment. Phone interviews with 
prospective DTC-GT customers were conducted during the summer of 2019. These 
customers were recruited from a panel from Ancestry, a family history and genetic 
genealogy company (Ancestry, 2020). The aim of these interviews was to understand 
which factors from Rogers’ theory and also health-communication, information-seeking, 
and privacy management theories would be the most important in either serving as a 
motivation for or barrier to DTC-GT adoption. The results from these interviews will be 
used to lead the design and focus for the issue-specific media framing experiment in 
Study II. The following research questions guided these interviews for Study I: 
RQ1: What are the main motivations for prospective customers to take a direct-to-
consumer genetic test for health information? 
RQ2: What are the main barriers which could prevent prospective customers from 






Participants and Procedure 
20 Ancestry customers were recruited for phone interviews to identify initial 
insight into DTC-GT adoption. These participants were a convenience sample composed 
of Ancestry family history customers (N = 10), and AncestryDNA customers (N = 10). 
This convenience sample was chosen because the researcher of this dissertation is a User 
Experience Researcher at Ancestry, and conducts studies over the AncestryHealth 
offering. Ancestry is one of the largest genealogy companies in the industry, and its DNA 
customer database spans over 18 million people (Ancestry, 2020). Ancestry is an online 
family history resource that offers its subscribing customers the ability to search through 
billions of records (such as census, birth, marriage, death) to build their family tree. 
Please note that the term “family history customers” is referring to those who purchased a 
subscription to Ancestry’s “family history resource” service, and not those with a family 
health history of a medical condition. Subscribers of their family history services are 
called ACOM customers. Ancestry also provides DNA testing for ancestry information. 
Customers of the DNA services are called ADNA customers. Although these participants 
are a convenience sample due to the researcher’s affiliation with the Company as a user 
experience researcher, past literature shows that users may be more likely to adopt an 
innovation if they have used a similar innovation in the past (Rogers, 2003). In this case, 
AncestryDNA customers who have taken a DNA test for ancestry information could be 
more likely to adopt another type of DNA testing such as for health. 




Upon being logged in to the Ancestry site, participants saw a pop-up asking if they would 
be interested in participating in a phone interview around emerging DNA technologies. 
Those in the family history group (ACOM) were recruited from the logged in home page 
for family history (ACOM LIHP).  These ACOM customers had an age range between 25 
and 63 years. Participants in the ADNA group were recruited directly from the DNA 
logged in homepage on Ancestry (DNA LIHP). The DNA group respondents had an age 
range between 24 and 50 years. 
After agreeing to a consent form, which was sent to participants via email to fill 
out, participants were first asked questions regarding their familiarity with DNA testing 
for health information. Participants were then asked what would motivate them to take a 
DNA test for health information or serve as a barrier to taking the test. After hearing the 
participants’ thoughts organically, questions were asked specifically regarding their 
thoughts from topics in the aforementioned literature (e.g. for Communication Privacy 
Management: “What are your thoughts on how these companies address data privacy?; 
for Health Belief Model’s Perceived Susceptibility: “Can you tell me about a scenario in 
which you would take this type of test for health information? Such as ruling out a 
specific condition?” A full list of the interview questions is within the appendix. 
Each phone interview lasted between 45 minutes to 1 hour. All participants were 
compensated in the form of a $50 Amazon gift card sent to their email address. 






This study employed a method for analysis called “template analysis,” which 
incorporates both inductive and deductive approaches to coding interview transcripts. 
Template analysis begins with a priori codes / themes and allows them to be revised or 
removed as part of the analysis process. In this study, an a priori set of codes were 
applied to the first five interview transcripts by two coders: BA, the principal investigator 
of this dissertation research and a user experience researcher at Ancestry, and DW, a 
principal user experience researcher at Ancestry.  Prior to coding, the two coders met to 
go over the coding protocol and discuss the code sheet in depth. The full coding sheet can 
be found within the appendix. The initial a priori codes were based off of literature 
discussed in Chapter III which revolved around technology adoption and evaluation, 
health behavior, information-seeking behavior, and privacy management. As these five 
interviews were coded, the template was revised, and emergent thematic codes were 
added to create the final template. Once the final template was agreed upon by the coders, 
the coding template was re-applied to the five interview transcripts by two coders (BA, 
DW) to ensure intercoder consistency, and then the remaining 15 transcripts were coded 
by one coder (BA). The final themes derived from the interviews were used to refine the 







20 interviews were conducted to gain initial insight into users’ perceptions of 
direct-to-consumer genetic testing for health information and address RQ1 and RQ2. 
Thematic saturation was reached after 10 interviews (5 family history customers and 5 
DNA customers). Thematic saturation was defined by the coders when no new themes or 
patterns were emerging from the data. From the results, participants reported they would 
purchase a DTC-GT because they thought it could provide them with beneficial health 
information and enable them to begin taking proactive health measures if they were at 
higher risk for a health condition. Other motivations for taking the test included the 
perceived relative advantages to taking a DTC-GT over seeing a medical provider in-
person, such as convenience and cost of testing. Even if participants thought the test 
could provide someone with “useful” or “beneficial” information, there were factors that 
would ultimately outweigh their decision to take a test. These factors include whether or 
not an individual believed they were susceptible to a condition, concerns over data 
privacy, and whether or not they wished to know they had a risk for a health condition. 




Absolute Advantage/Perceived Beneficial Outcomes of Genetic Testing 
Interviewed participants stated they would be inclined to purchase a DTC-GT 




One of the first beneficial outcomes participants listed was the ability to find out health 
information they may not have known about, either due to not knowing if a condition 
runs in their family or if they were adopted and did not have access to any medical 
information. Some participants expressed they were unable to easily find out their risk for 
certain conditions due to having missing medical records or not knowing their biological 
parent(s): “I found out my biological father was not who I thought he was through this 
DNA test,” one participant states, “I had based my previous medical information on his. I 
would take this test to be able to find out information about my health that I didn’t have 
before.” Another participant expressed similar sentiment on taking the test to gather 
information they had before and to be able to take proactive health measures: “I always 
knew I was adopted, but never had a background for my health history; taking this test 
would finally enable me to learn what I might be susceptible to so I can take preventative 
measures.” 
Some individuals expressed they had known about various health conditions in 
their family and subsequently valued being able to take a DNA test for health to see if 
they were at risk, too: “Heart disease runs in my family,” one participant said, “I’d want 
to know if I have high cholesterol or a heart condition too.” Others reported a similar 
sentiment about taking the test to confirm a family history with cancer: “My family has a 
history of cancer; I would take this test to know if I am likely to get cancer too.” 
Participants stated this type of testing was helpful for the early detection of conditions 
and proactive planning: “It is very helpful; if I know I am more likely to have high 




motivation for taking the test. Another participant said the information this test could 
provide was “life changing” and “it would be helpful to know if I am at risk for cancer 
because I can more actively get cancer screenings.” 
 
Relative Advantage 
Participants also expressed how they thought DTC-GT had benefits compared to 
seeing a doctor for in-person genetic testing. Four individuals who had taken a DNA test 
for health information through their medical providers said it was a long process. These 
four participants specifically recalled the process of scheduling appointments for initial 
test planning, scheduling another appointment to submit a DNA sample, and then follow-
up appointments to go over the results from testing: “It was a long process,” one 
participant remarked, “I’m glad I got testing done, but the DTC-GT process seems to 
much more convenient than what I went through with my provider.” While these 
participants expressed it was good to get their health information, the DTC-GT approach 
would allow them to “quickly get their DNA results without leaving home.” 
Other perceived advantages by participants included the number of tests a DTC-
GT offered in comparison to testing through a medical provider. “When I went through 
testing with my doctor, we only tested for things like cystic fibrosis because I was 
pregnant,” one participant commented, “the types of conditions this testing [DTC-GT] 
offers seems to be a much higher number than what I was offered from my doctor.” 
Some participants also had the impression that taking a DNA test through a 




a medical provider.  
 
Perceived Susceptibility  
Another factor that participants said would either increase or decrease their 
likelihood of taking the DTC-GT is whether or not they felt they were susceptible to the 
specific health conditions tested for. Some participants reported to know that certain 
conditions like high cholesterol or breast cancer ran in their family and as such they 
would pursue testing to determine their own risk levels: “My mother and grandmother 
both had breast cancer; it is very important that I get tested because I am very 
susceptible.” Other comments from interviewees echoed this sentiment of susceptibility: 
“I know Alzheimer’s disease runs in my family,” one participant said, “I am concerned 
that I may be at risk and want to get tested.” 
Conversely, when interviewing some users, they mentioned their age would be a 
deterrent to taking the test: “I am 60. If I were going to get cancer or have high 
cholesterol, I would know by now,” one participant stated, “I don’t think the results will 
make an impact. If it’ll happen it’ll happen.” Another participant echoed similar 
sentiments with regard to age and their risk level: “I would have taken this if I were in my 
20s or 30s, but not now. I can’t do too much now.” Interviewees with older relatives who 
never had a history of health problems said they did not think they’d be susceptible 
either: “Everyone in my family has lived well past 90 years old and has never had an 







When asked about what might serve as a barrier to taking a DNA test for health 
information, privacy was the most reported concern. 18/20 participants said their 
likelihood of adopting DTC-GT would be dependent on the genetic testing company’s 
privacy policy and clarity over how their genetic data would, if at all, be shared. “I don’t 
want to start seeing medical ads based on my results,” one participant commented, “I 
want to be in control of who has access to my health results.” Participants stated they 
would want clear and specific information regarding how their health results would be 
stored, used, and maintained. Interviewees stated they would not mind if their results 
were used for health research or for law enforcement purposes, but wanted transparency 
and the ability to opt in or out of any data sharing. 
Participants commenting on data privacy also expressed concern over health 
insurance ramifications. “Would I have higher insurance premiums?” one participant 
asked. “Would I be denied coverage for having a preexisting condition?” another 
participant worried. These individuals did not feel like their health insurance should be 
able to access their results, nor would they share their results with their health insurance. 
Those familiar with the Genetic Information Non-Discrimination Act (GINA) said the 
insurance companies will still find a way around providing coverage. “Insurance won’t 
say they are denying me [coverage] for this inherited condition, but they will say it is 
denial for something else entirely.” one individual commented. “Insurance companies are 




Desire for Uncertainty  
Another reported barrier to DTC-GT adoption for participants was the aspect of 
“not wanting to know” if they were at risk for a specific health condition. Some 
interviewees did not want to know if they were at risk for a health condition as it could 
make them feel “fearful” or “anxious” if they found a positive result. “It would be scary 
for me to know. I’d rather not know” one interviewee remarked. “I don’t want to live in 
fear or worry about it. If it happens it happens. I’ll take care of it when it happens” 
another participant stated. These users indicated the only factor that would get them to 
take the test was if their family wanted the health information or if it were a medical 
necessity. 
 
Financial Costs  
One of the other main potential barriers discussed by participants was the cost of 
the DNA test for health information. Interviewees expressed that they were not exactly 
sure how much this type of DNA test would cost. Although some indicated in the 
“Relative Advantage” section that they believed it would be more cost-efficient than 
seeing a medical provider, others were unsure how much the testing would cost through 
the company, and did not know if they would be able to afford the purchase: “I have 
already purchased a DNA test for my ethnicity estimate from Ancestry,” one interviewee 







 These interviews were conducted to gain insight into RQ1 and RQ2, inquiring 
about which factors would be the biggest motivators or deterrents to DTC-GT adoption. 
In addressing RQ1, which sought to understand the main motivations to taking a DTC-
GT for health information, the perceived benefits or advantages of testing were a clear 
motivator. Participants who thought this type of testing could provide them with 
beneficial health insights reported to be more likely to purchase a test. This idea is related 
to the Health Belief Model’s Perceived Benefits, which is a person’s belief that the 
engagement with a specific health behavior or action will result in positive outcomes 
(Hochbaum, Rosenstock, & Kegels, 1952). This also supports past research where the 
Perceived Benefits of a health behavior led to higher intent for engagement (Darvishpour, 
Vajari, & Noroozi, 2018; Hochbaum, Rosenstock, & Kegels, 1952).  
 RQ1 also found the perception of DTC-GT’s “convenience” or “benefits” 
compared to testing through a medical provider to be associated with intent to adopt. 
Interviewees stated that they would be more likely to adopt DTC-GT based on how they 
could take the test and receive their results without leaving their home. In addition, 
participants believed DTC-GT could offer more health reports and would cost less overall 
than in-person testing via a medical provider. This is in support of Rogers’ TPA, 
specifically Relative Advantage, which measures the extent that the innovation is seen to 
be better than what it supersedes (Rogers, 2003). In this case, if prospective customers 
believe that DTC-GT has benefits or “relative advantages” to testing through a medical 




Rogers’ original model for adoption based on perceived attributes. 
 Another insight discovered in RQ1 was that the perception of susceptibility would 
have an impact on the likelihood to adopt DTC-GT. Participants who knew specific 
conditions ran in their family reported to be more inclined to adopt the testing. This 
relates to Perceived Susceptibility within the Health Belief model, which refers to the 
person’s perception of their risk of acquiring a disease, condition, or illness (Hochbaum, 
Rosenstock, & Kegels, 1952). Other research has found Perceived Susceptibility to be 
correlated with engagement in healthy behaviors such as smoking cessation (Hochbaum, 
Rosenstock, & Kegels, 1952; Li et al., 2003). Altogether, this finding in RQ1 is in 
support of past research in health behavior. 
For RQ2, which looked to gain insight into main barriers to taking this type of 
DNA test, participants exclaimed privacy boundaries or potential loss of ownership of 
private information would be a major deterrent to taking the test. This concern over 
privacy is in alignment with research from the theory of Communication Privacy 
Management (Petronio & Altman, 2002). Other factors that arose with the discussion of 
privacy included fear of health insurance ramifications. Participants were concerned over 
whether their data could be shared with their insurance companies and possibly result in 
higher premiums or denied coverage. This fear of insurance repercussions echoes prior 
studies’ findings on privacy concerns with relation to health insurance (Williams et al., 
1999). Although participants reported to be highly concerned with privacy, almost all of 
the individuals had taken a prior DNA test for ancestry information or an ethnicity 




health is widely seen as more private or confidential information than DNA for ancestry 
information. 
This idea of privacy concerns not being met to individuals’ standards also relates 
to Rogers’ Compatibility attribute, which relates to how an innovation is consistent or 
contrasts with the overall needs of potential adopters (Rogers, 2003). Other aspects 
supporting Rogers’ Compatibility attribute include participants’ comments on the cost of 
the test, and how expensive it seemed. 
RQ2 also shed light on how the desire for uncertainty may deter prospective 
customers from taking a DTC-GT. Several participants expressed that they would not 
want to know if they were at risk for a certain condition, as it could evoke feelings of 
“anxiety” or “fear.” This is in alignment with research from the Theory of Motivated 
Information Management. Past studies have found that persons may experience health-
related uncertainty as a positive state (Fanos & Johnson, 1995; Lerman et al., 1999). 
Furthermore, additional studies have found that it is relatively common for individuals to 
specifically avoid health information to maintain uncertainty (Barbour, Rintamaki, 
Ramsey, & Brashers; 2012; Sairanen & Savolainen, 2010). This idea of the individual’s 
desire for uncertainty serving as a barrier for individuals to take a DTC-GT is in support 
of past research from TMIM and information-seeking behavior. 
Since the main goal of this study was to refine Rogers’ model, it is important to 
address that three of his attributes, Complexity, Trialability, and Observability, were not 
listed by participants to have much impact on their intent to adopt DTC-GT. The 




as much of an impact on their plans to take the test. Trialability in this sense is not as 
relevant to DTC-GT, as one “cannot easily sample a DNA test or its results” participants 
stated. This is inconsistent with previous literature on how health professionals approach 
the adoption of technology within the medical field. Prior research on how healthcare 
professionals approach adoption indicated that Observability and Trialability to be 
important factors leading up to adoption (Coleman et al., 1966, Gabbay & le May, 2004). 
This suggests that all of the needs for those working in the medical field are not as 
applicable to consumers’ needs when considering adoption of health innovations. 
The following chapters of this dissertation will further discuss this proposed 
refined model (Chapter V), detail testing the refined attributes in a media framing 






CHAPTER V: PROPOSING A REFINED PERCEIVED ATTRIBUTES MODEL 
FOR CONSUMER HEALTH INNOVATION ADOPTION 
This chapter will discuss the proposal of a new model for predicting media 
framing effects related to DTC-GT adoption intent and research hypotheses for the issue-
specific media framing experiment in Chapter VI. Based on the interview results from 
Study I and relevant literature detailed in Chapter III, a refined model for Rogers’ Theory 
of Perceived Attributes is proposed to meet the direct-to-consumer genetic testing 
environment. The refined model was designed based on the prevalent themes within the 
interviews and previously discussed literature. For example, the main predictors 
(horizontal arrows) and moderators (vertical arrows) had supporting literature discussing 
the relationships (Health Belief Model, Theory of Motivated Information Management, 
Theory of Perceived Attributes) and these findings were reinforced within the user 









As detailed in Chapter III: Theoretical Frameworks, scholarship in the area of 
media framing has found that issue-specific frames are able to positively affect 
individuals’ thoughts on a certain topic (De Vreese et al., 2001; Guenduez, Schedler, & 
Ciocan, 2016; Jackson, 2010; Kozman, 2017; Schuk & De Vreese, 2006). As exposure to 
framed messages are expected to facilitate belief outcomes, it is reasonable to suggest 
that exposure to an issue-specific media frame will lead to an increased belief in the 
advantages of direct-to-consumer genetic testing technology. From Study I, prospective 
user interviews found that individuals who believed DTC-GT could provide beneficial 
health information expressed a higher intent to purchase a test. This is consistent with 
health theory stating if one believes there are benefits of a health-related behavior, intent 
to engage will be higher (Hochbaum, Rosenstock, Kegels, 1952). From the theoretical 
literature and findings from Study I, exposure to a news article discussing the “absolute 
advantage” of direct-to-consumer genetic testing is predicted to lead to an increased 
belief in the advantages of the innovation and, in turn, a higher adoption intent: 
H1: Exposure to the Absolute Advantage frame will lead to a higher likelihood of 
adoption than if not exposed to this frame. 
 Additionally, from Rogers’ “Relative Advantage” criteria, if an innovation is 
seen to have an advantage over what it supersedes, there will be a higher intent to adopt 
(Rogers, 2003). Study I echoed these findings, where prospective DTC-GT customers 
said they would be more likely to purchase a consumer genetic test because of its 
convenience and cost compared to a medical provider. From Rogers’ model and findings 




technology, or how it is potentially more convenient than in-person testing through a 
medical provider, is predicted to lead participants to have an increased belief in the 
relative advantages of this technology and subsequently result in a higher adoption intent. 
From this information, the following hypothesis is proposed: 
H2: Exposure to the Relative Advantage frame will lead to a higher likelihood of 
adoption than if not exposed to this frame. 
Based on the literature in Chapter III and the results from Study I, it was found 
that an individual’s privacy boundaries, desire for uncertainty, and perceived 
susceptibility can serve as barriers to adoption. Firstly, the large majority of participants 
stated that their privacy concerns could deter them from taking such a health test. This 
idea of privacy being an important factor affecting DTC-GT adoption is in alignment 
with past research on privacy management. Prior studies have shown that individuals 
consider private information to be something they own and want control over (Petronio & 
Altman, 2002). Additionally, studies have found that health information is generally 
considered more sensitive and it is typical for individuals to have thicker privacy 
boundaries around such information (Petronio & Altman, 2002). With this in mind, the 
current study proposes that individuals with stronger privacy boundaries will be less 
likely to adopt DTC-GT overall within the Absolute Advantage and Relative Advantage 
conditions. These ideas are outlined in the following hypotheses: 
H1a: The relationship between exposure to the Absolute Advantage frame and the 





H2a: The relationship between exposure to the Relative Advantage frame and the 
likelihood of adoption will be weaker among people with stronger privacy 
boundaries. 
It is also important to address that privacy will be the focal point of the 
Compatibility issue-specific framed article in Study II. While other potential aspects of 
Compatibility were discussed in the prospective user interviews, such as the pricing of 
the DTC-GT, privacy was one of the key compatibility needs that interviewees expressed 
they needed to have further information about, in addition to one that could be framed 
easier within a news article. Since the Compatibility frame will discuss privacy and data 
protection standards of DTC-GT, it is proposed that those with privacy concerns will be 
more likely to adopt DTC-GT in this condition from having further information to 
address their privacy concerns. This is put into one hypothesis because the Compatibility 
frame is predicted to be compatible with one’s privacy concerns through its discussion of 
data privacy standards. 
H3: The relationship between exposure to the Compatibility (Privacy) frame and 
the likelihood of adoption will be stronger among people with stronger privacy 
boundaries. 
Regarding Desire for Uncertainty, prior research has shown that individuals may 
prefer to remain unaware of their health status, for knowing could result in increased 
anxiety (Afifi & Weiner, 2006; Fanos & Johnson, 1995; Lerman et al., 1999). In this 
sense, a high desire for uncertainty would result in an individual being less likely to adopt 




interviews, where some individuals expressed that, despite the perceived benefits of 
health testing, they would not want to know if they were at an increased risk of a 
potentially “scary” or “anxiety-inducing” health condition. From this information on 
one’s Desire for Uncertainty and likelihood of adopting DTC-GT, the following 
hypotheses are proposed: 
H1b: The relationship between exposure to the Absolute Advantage frame and the 
likelihood of adoption will be stronger among people with a lower desire for 
uncertainty. 
H2b: The relationship between exposure to the Relative Advantage frame and the 
likelihood of adoption will be stronger among people with a lower desire for 
uncertainty. 
Furthermore, scholarship from the Health Belief Model has found that one’s 
increased perceived risk, or perceived susceptibility, of developing a health-related 
condition can lead to a higher likelihood of health-behavior engagement or adoption 
(Hochbaum, Rosenstock, & Kegels, 1952; Li et al., 2003). Study I also found that 
prospective DTC-GT customers reported to be more likely to adopt DTC-GT based on 
their own perceived risk of developing a health condition. In addition, individuals 
interviewed in Study I with a low perceived susceptibility reported to be less likely to 
adopt DTC-GT, despite acknowledging the benefits of the technology. With this in mind, 
both research from health-behavior theory and Study I suggest that if an individual has a 
high level of perceived susceptibility, it will in turn increase their likelihood of adoption 





H1c: The relationship between exposure to the Absolute Advantage frame and the 
likelihood of adoption will be stronger among people with higher perceived 
susceptibility. 
H2c: The relationship between exposure to the Relative Advantage frame and the 
likelihood of adoption will be stronger among people with higher perceived 
susceptibility. 
Altogether, the research proposes the following: the relationship between absolute 
advantage and intent to adopt is hypothesized to be moderated by privacy boundaries, 
desire for uncertainty, and perceived susceptibility. The relationship between relative 
advantage and intent to adopt is also hypothesized to be moderated by privacy 
boundaries, desire for uncertainty, and perceived susceptibility. The relationship between 
exposure to the compatibility frame and intent to adopt is hypothesized to only be 
moderated by privacy boundaries in this study, as the frame focuses on privacy needs. 
This proposed model and associated hypotheses will be tested via a framing effects 






CHAPTER VI: STUDY II – TESTING THE REFINED ATTRIBUTES THROUGH 
ISSUE-SPECIFIC MEDIA FRAMING EXPERIMENT 
From the aforementioned literature and results from Study I, this dissertation 
proposes a refinement to Rogers’ model for the direct-to-consumer genetic testing 
environment. As stated in Chapter III: Theoretical Foundations, there is no standardized 
frame used within a health context to predict the adoption of a consumer health 
innovation. Currently, most media frames employed in health communication research 
differ conceptually and methodologically (Kozman, 2016; Matthes & Kohring, 2008; 
Scheufele & Tewksbury, 2007), and may not fully consider the nuances of a consumer 
health innovation. Study II seeks to address this gap by creating a media framing 
approach via issue-specific frames to be measurable and replicable in future studies 
examining consumer health innovation adoption. Study II will examine the effects of 
issue-specific media framed messages based on the refinement of Rogers’ criteria 
(Absolute Advantage, Relative Advantage, Compatibility) on the intent to adopt direct-
to-consumer genetic testing for health information. Study II will also consider the role of 
moderating factors, including one’s privacy boundaries, desire for uncertainty, and 
perceived susceptibility on the intent to adopt. Chapter V discusses the hypotheses for 
this research in further detail. 
 
Methodology 
Participants and Procedure 




were recruited from a paid Qualtrics panel sample. The purchased panel was for a general 
population of varying demographics including gender, age, education levels, ethnicity, 
and income level. The sample size of 380 was chosen based on available funding for the 
research. Out of all participants, there was an age range between 18 to 82 years (M = 
44.39, SD = 16.58). 48.2% of respondents identified as male, 51.1% identified as female, 
and 0.7% identified as non-binary. The sample included participants who identified as 
White (75.3%), Hispanic or Latino (5.8%), Black or African American (11.3%), Native 
American and/or Alaskan Native (0.5%), Asian (5.0%), Pacific Islander (0.5%). 0.16% of 
respondents did not indicate their race. 
For education 2.9% reported some high school or less, 16.6% had a high school 
diploma, or equivalent, 2.4% had an occupational/vocational degree, 25.3% had taken 
some college classes but no degree, 10.8% had an Associate’s degree, 23.4% had a 
Bachelor’s degree, 12.4% had a Master’s degree, 6.1% had a Doctorate. 51% of 
respondents reported to have children while 47.4 did not. 1.6% preferred not to answer 
whether they had children. When asked about employment status, 40.8% reported to 
work full time, 12.4% were working part time, 6.1% were unemployed and looking for 
work, 6.3% were unemployed and not looking for work, 5.0% were students, 15.8% were 
retired, 5.0% were self-employed, and 8.7% were unable to work. There were varying 
income levels including: 7.6% had an annual household income below $10,000, 10.3% 
reported $10,000 – $20,000, 30.3% stated they earned $20,000 – $50,000, 21.8% 
reported $50,000 – $80,000, 6.6% reported $80,000 – $100,000, 8.4% stated $100,000 – 




3.2% had an annual household income over $250,000. None of the 380 respondents had 
taken a DTC-GT for health information; this was a screening criterion to determine if a 
media frame would increase their likelihood of adoption. 
After agreeing to a consent form, participants were randomly assigned to one of 
four conditions: (0) control group – no specific frame exposure, (1) absolute advantage 
frame exposure, (2) relative advantage frame exposure, (3) compatibility (privacy) frame 
exposure. A breakdown of the differences between the four conditions can be found in 
Table 1 within the Stimuli section. This between-subject design was employed in order to 
mitigate order effects between the various news articles and avoid time-based effects 
such as participant fatigue or performance experience (Reeves & Geiger, 1994). More 
detail about the articles can be found in the stimuli section below. The participants would 
read the media framed article for their condition and then proceed to answer survey 
questions to measure the dependent and moderating variables in question. Quality control 
questions were set up to prevent spam responses (e.g., Please select “none of the above” 




Absolute Advantage was adapted from the Health Belief Model’s Perceived 
Benefits (Hochbaum, Rosenstock, & Kegels, 1952). An example item was: “I think this 
type of genetic health test can provide important information for my family (e.g. my 




(Cronbach’s α = .927, M = 4.96, SD = 1.37). This variable was intended to measure the 
manipulation check for the Absolute Advantage frame. 
 
Relative Advantage 
Relative Advantage was adapted from Rogers’ Theory of Perceived Attributes 
(Rogers, 2003). An example item was: “I think taking a direct-to- consumer genetic test 
for health is more convenient than going through my own doctor.” All of the measures (5 
total) were on a 7-point Likert scale (Cronbach’s α = .641, M =4.09, SD = 0.98). The 




Compatibility was adapted from Rogers’ Theory of Perceived Attributes (Rogers, 
2003). An example item was: “The information that direct-to-consumer genetic testing 
can provide me with is valuable.” All of the measures (4 total) were on a 7-point Likert 
scale (Cronbach’s α = .94, M =4.78, SD = 1.41). This variable served as the manipulation 
check for the Compatibility frame. 
 
Desire for Uncertainty 
Desire for Uncertainty was adapted from (Afifi & Weiner, 2006). An example 
item was: “I would rather not know if I am at an increased risk for a specific health 




.78, M =3.12, SD = 1.48). This variable was one of the proposed moderators that would 
have an interaction effect with frame exposure and intent to adopt. 
 
Privacy Boundaries 
Privacy Boundaries was adapted from (Petronio & Altman, 2002). An example 
item was: “Providing this direct-to- consumer genetic testing service with my personal 
information would involve many unexpected problems.” All of the measures (5 total) 
were on a 7-point Likert scale (Cronbach’s α = .94, M =4.68, SD = 1.41). This variable 
was also a proposed moderator that would have an interaction effect with frame exposure 
and intent to adopt. 
 
Perceived Susceptibility 
Perceived Susceptibility was adapted from (Hochbaum, Rosenstock, & Kegels, 
1952). An example item was: “The possibility that I am at risk for a health condition (e.g. 
cancer, high cholesterol, or Alzheimer’s disease) is very high.” All of the measures (5 
total) were on a 7-point Likert scale (Cronbach’s α = .91, M =4.01, SD = 1.49). This 
variable was the third of the proposed moderators to have an interaction effect with frame 
exposure and intent to adopt. 
 
Likelihood of Adoption 
Likelihood of adoption was adapted from (Rogers, 2003). Participants were asked 




next 6 months. All of the measures (3 total) were on a 7-point Likert scale (Cronbach’s α 
= .90, M =3.26, SD = 1.79). Likelihood of Adoption was the main dependent variable 
throughout this study. 
 
Stimuli 
Four different issue-specific, media framed news articles were created by the 
researcher to serve as stimuli within this study. The articles were modeled after and 
adapted from actual news articles on DTC-GT. Each article contained a neutral overview 
of direct-to-consumer genetic testing (which is the control group article), and then would 
have an extra paragraph “add-on” depending on their condition which was the issue-
specific media frame. Depending on the randomly assigned condition, participants were 
asked to read an issue-specific news article framed by one of the refined criteria: 
Absolute Advantage, Relative Advantage, or Compatibility (Privacy). A control group 
was present to compare the effect of the added media frame.  
Participants were randomly assigned to one of four conditions: (0) control group, 
(1) absolute advantage, (2) relative advantage, (3) compatibility. The stimuli and 






Description of Articles and Conditions. 
Condition Title Article description 
0 Control Group Base article consisting of a neutral overview of DTC-GT (present in every article) 
1 Absolute Advantage Base article + additional section discussing benefits of DTC-GT testing.  
2 Relative Advantage Base article + additional section comparing DTC-GT testing to going through a medical provider 
3 Compatibility 
Base article + additional section detailing data 
privacy standards and opting-in to consent for data 
sharing. 
 
Pretesting of the Articles and Survey 
A small qualitative pretest was conducted before widespread launch of the 
experiment to evaluate the article content and ensure the main focus of the articles were 
clear. The pretest consisted of a convenience sample with 20 of the researcher’s 
coworkers who were not affiliated with the research study and were unfamiliar with 
media framing. Five individuals were assigned to read one out of the four articles. After 
reading their assigned article, the participants were asked to state the purpose of the 
article they read and to briefly describe the main points of the article they read. 
Participants were able to clearly articulate the purpose of the articles.  
After the articles and survey flow were finalized, an additional pretest was 
conducted for the full article and survey flow. Approximately 15 individuals not affiliated 
with the study or research ran through the survey and checked for any errors and 




with the flow to mitigate potential confusion. 
Following the second pretest, the researcher worked with Qualtrics on a “soft 
launch” with Qualtrics panelists to ensure the flow and data were correct, and there were 
no glaring or concerning issues with the flow or questions. 
 
Manipulation Check 
A manipulation check was performed to measure how participants perceived the 
issue-specific framed content. This test was conducted via a series of independent 
samples t-tests to compare the manipulated variables of each framed group to the control 
group (e.g. how those in the Relative Advantage group scored on the Relative Advantage 
measure compared to the scores of those in the control group). The first independent 
samples t-test was performed to compare the mean Relative Advantage scores of the 
Relative Advantage condition to the control group. Those in the Relative Advantage 
condition (M = 4.28, SD = .92, N = 95) ranked DTC-GT higher in having a Relative 
Advantage than those in the control group (M = 3.79, SD = .79, N = 95), t(188) = 3.99, p 
= .000, two-tailed, indicating the manipulation was successful.  
Next, an independent samples t-test was conducted to compare the mean Absolute 
Advantage scores of the Absolute Advantage condition group to the control group. Those 
in the Absolute Advantage condition (M = 5.14, SD = 1.37, N = 95) ranked DTC-GT 
higher in having an Absolute Advantage than those in the control group, but this result 
was not statistically significant (M = 4.79, SD = 1.31, N = 95), t(188) = 1.82, p = .07, 
two-tailed. While this result approached statistical significance, the p value greater than 
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.05 indicates the manipulation in the Absolute Advantage group was not successful. 
Lastly, a manipulation check was conducted for the Compatibility group by 
comparing the mean Compatibility scores of the Compatibility condition group to the 
control group. Those in the Compatibility condition (M = 4.96, SD = 1.35, N = 95) had a 
higher and statistically significant ranking for DTC-GT seeming to be more compatible 
with their needs than the control group (M = 4.54, SD = 1.36, N = 95), t(188) = 2.2, p = 
.031, two-tailed. These results indicate that manipulation via media frame was successful 
for the Relative Advantage and Compatibility groups, but not for the Absolute Advantage 
group. As a result, the results for the Absolute Advantage group are not expected to be in 
support of the corresponding hypotheses: H1, H1a, H1b, and H1c. 
Data analysis 
This study used three hierarchical regressions to examine the impact of frame 
exposure on the likelihood of adopting DTC-GT and to consider potential interaction 
effects. Each model was built with three blocks: Block one consisted of demographics 
(age, race, gender, education, income, previous DNA test experience, and the proposed 
moderating variables (privacy boundaries, desire for uncertainty, perceived 
susceptibility). Block two included exposure to the media frame (Absolute Advantage, 
Relative Advantage, or Compatibility). Block three consisted of proposed interaction 
terms: Frame exposure ✕ Privacy Boundaries, Frame exposure ✕ Desire for Uncertainty, 
Frame exposure ✕ Perceived Susceptibility. 
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Results 
Study II examines the effects of media framing on intent to adopt a consumer 
health innovation, while considering the proposed interaction effects of privacy 
boundaries, desire for uncertainty, and perceived susceptibility. Overall, the study found 
that there was a main framing effect with the Absolute Advantage frame on the intent to 
adopt DTC-GT. Additionally the study found there were two interaction effects present: 
1) Desire for Uncertainty in the Absolute Advantage framed condition, and 2) Perceived
Susceptibility in the Relative Advantage frame condition. The results per each hypothesis 
are further discussed in the corresponding paragraphs. 
H1 predicted that exposure to the issue-specific media frame Absolute Advantage 
would lead to a higher likelihood of adoption than if not exposed to one of the frames 
(control group). Results from a hierarchical regression show that Absolute Advantage 
frame exposure significantly predicts likelihood of DTC-GT adoption: (Model 2: β = .13, 
SE = .20, p < .05). When an individual reads a news article framed to emphasize the 
Absolute Advantage of DTC-GT, they have a higher likelihood of adoption than those 





Hierarchical Regression Results for Exposure to the Absolute Advantage Frame on 
Intent to Adopt DTC-GT. 
 Model 1 Model 2 Model 3a Model 3b Model 3c 
Block 1 – Baseline 
Model      
Age -0.15* -0.14* -0.14* -0.14* -0.14* 
Race (White/Non-
White) -0.02 -0.03 -0.03 -0.04 -0.03 
Gender -0.24*** -0.25*** -0.25*** -0.26*** -0.25*** 
Education -0.06 -0.05 -0.05 -0.07 -0.05 
Income 0.16* 0.17* 0.17* 0.18** 0.18* 
Previous DNA Test -0.10ᵗ -0.1* -0.09ᵗ -0.09ᵗ -0.09 
Privacy Boundaries -0.17** -0.17** -0.22* -0.17** -0.18** 
Desire for 
Uncertainty -0.42*** -0.41*** -0.41*** -0.28** -0.41*** 
Perceived 
Susceptibility 0.07 0.07 0.07 0.07 -0.01 
Block 2 – Frame 
exposure      
Exposure to AA 
Frame  0.13* 0.13* 0.13* 0.13* 
Block 3a–c - 
Interaction terms      
AA Frame X 
Privacy   0.05   
AA Frame X Desire 
for Uncertainty    -0.19*  
AA Frame X 
Perceived 
Susceptibility 
    0.11 
R² 0.47*** 0.49*** 0.49*** 0.50*** .49*** 
ΔR² 0.44*** 0.46*** 0.45*** 0.47*** .46*** 
Note: ᵗp < .1. * p <; .05. ** p < .01. *** p < .001. 
Cell entries are final-entry OLS standardized coefficients (β). N = 190 





In order to address H1a–c, which consider the moderating effects of the proposed 
moderating variables Privacy Boundaries, Desire for Uncertainty, and Perceived 
Susceptibility on the strength of the Absolute Advantage frame, additional regression 
models were analyzed.  For H1a, which hypothesized a moderating effect of Privacy 
Boundaries on the relationship between exposure to the Absolute Advantage frame and 
the likelihood to adopt DTC-GT, there was no statistically significant interaction present.  
In addressing H1b, which hypothesized that one’s Desire for Uncertainty would 
interact with exposure to the Absolute Advantage frame to predict the likelihood of 
adoption, a statistically significant effect was found (Model 3b: β = -.19, SE =.14, p < 
.05). These results support H1b, suggesting that the framing effect on adoption intent is 
stronger for those who have a lower desire for health-related uncertainty compared to 
those with a higher desire. Figure 3 illustrates this interaction effect: 












Lastly, in addressing H1c, which hypothesized that one’s Perceived Susceptibility 
would interact with exposure to the Absolute Advantage frame to predict the likelihood 
of adoption, a statistically significant interaction effect was not found. H1c is not 
supported.  
H2 predicted that exposure to the issue-specific media frame Relative Advantage 
would lead to a higher likelihood of adoption than if not exposed to one of the frames 
(control group). Results from a hierarchical regression show that this framing effect was 
not significant. That is, H2 is not supported.  
In order to address H2a–c, which considered the moderating effect of the 
proposed variables Privacy Boundaries (H2a), Desire for Uncertainty, and Perceived 
Susceptibility on the effect of the Relative Advantage frame on the adoption intent, 
additional analyses were conducted. For H2a, which hypothesized a moderating effect of 
Privacy Boundaries on the relationship between the exposure to the Relative Advantage 
frame and the likelihood to adopt DTC-GT, there was no statistically significant 
interaction present.  
In addressing H2b, which hypothesized that one’s Desire for Uncertainty would 
interact with exposure to the Relative Advantage frame to predict the likelihood of 
adoption, no statistically significant interaction effect was found.  
Lastly, in addressing H2c, which hypothesized that one’s Perceived Susceptibility 
would interact with exposure to the Relative Advantage frame to predict the likelihood of 
adoption, a statistically significant interaction effect was found (Model 3c: β = .24, SE 




intent to adopt will be stronger for those with higher levels of Perceived Susceptibility, or 
increased perception of developing a condition. The reason this hypothesis is only 
partially supported is because the frame was only effective for those with high levels of 
Perceived Susceptibility. 
Figure 4. Interaction Effect of Perceived Susceptibility 
 
As one can see from Figure 4, the media framing effect on intent to adopt DTC-
GT is significantly stronger for those with a higher level of Perceived Susceptibility than 
those with a lower level of Perceived Susceptibility. Altogether, H2c was partially 
supported, but H2a and H2b were not supported. Further information on the statistical 














Hierarchical Regression Results for Exposure to the Relative Advantage Frame on 
Intent to Adopt DTC-GT. 
 Model 1 Model 2 Model 3a Model 3b Model 3c 
Block 1 – Baseline 
Model      
Age -0.23** -0.24*** -0.24** -0.24*** -0.23** 
Race (White/Non-
White) -0.09 -0.09 -0.09 -0.09 -0.09 
Gender -0.14* -0.14* -0.14* -0.14* -0.15* 
Education 0.14* 0.15* 0.14* 0.14* 0.15* 
Income 0.01 -0.001 .000 _ 0.00_ -0.01 
Previous DNA Test -0.08 -0.09 -0.09 -0.09 -0.09 
Privacy Boundaries -0.19** -0.19** -0.22** -0.21** -0.20** 
Desire for 
Uncertainty -0.35*** -0.36*** -0.35*** -0.25** -0.37*** 
Perceived 
Susceptibility 0.18** 0.18** 0.18** 0.19** 0.02 
Block 2 – Frame 
exposure      
Exposure to RA 
frame  -0.05 -0.05 -0.05 -0.04 
Block 3a–c - 
Interaction terms      
RA Frame X 
Privacy   0.05   
RA Frame X Desire 
for Uncertainty    -0.14  
RA Frame X 
Perceived 
Susceptibility 
    0.24** 
R² .40*** .40*** .40*** .40*** .40*** 
ΔR² .37*** .37*** .37*** .37*** .40*** 
Note: ᵗp < .1. * p <; .05. ** p < .01. *** p < .001. 
Cell entries are final-entry OLS standardized coefficients (β). N = 190 





H3 predicted that the relationship between exposure to the Compatibility 
(Privacy) frame and the likelihood of adoption will be positive and stronger among 
people with stronger Privacy Boundaries. A hierarchical regression was conducted to 
determine the effect of Privacy Boundaries as a moderating variable. There was no 
interaction effect found for this frame.  Further information on the statistics from this 
regression can be found within Table 4. 
 
Table 4. 
Hierarchical Regression Results for Exposure to the Compatibility Frame on Intent to 
Adopt DTC-GT. 
 Model 1 Model 2 Model 3 
Block 1 – Baseline Model    
Age -0.24** -0.23** -0.23** 
Race (White/Non-White) 0.06 0.06 0.06 
Gender -0.14* -0.1ᵗ -0.09ᵗ 
Education 0.07 0.06 0.06 
Income 0.07 0.09 0.09 
Previous DNA Test -0.08 -0.09 -0.09ᵗ 
Privacy Boundaries -0.29*** -0.28*** -0.21** 
Desire for Uncertainty -0.36*** -0.35*** -0.35*** 
Perceived Susceptibility 0.04 0.04 0.03 
Block 2 – Frame exposure    
Exposure to C Frame  0.11* 0.1ᵗ 
Block 3 – Interaction terms    
C Frame X Privacy   -0.09 
R² .48*** .49*** .50*** 
ΔR² .46*** .46*** .47*** 
Note: ᵗp < .1. * p <; .05. ** p < .01. *** p < .001. Cell entries are final-entry OLS 
standardized coefficients (β). N = 190 





While not hypothesized, it is important to acknowledge that there were main 
effects found for Privacy Boundaries and Desire for Uncertainty across all tested framing 
conditions. Privacy Boundaries had a statically significant main effect for the Absolute 
Advantage condition (Table 2, Model 1: β = -.17, SE =.11, p < .01), the Relative 
Advantage condition (Table 3, Model 1: β = -.19, SE =.10, p < .01), and the 
Compatibility condition (Table 4, Model 1: β = -.29, SE =.11, p < .01). This could 
indicate that, even when trying to address individuals’ privacy concerns, their own 
Privacy Boundaries may outweigh the decision to adopt regardless of information 
provided.  For Desire for Uncertainty, the regressions showed a main effect for the 
Absolute Advantage condition (Table 2, Model 1: β = -.42, SE =.10, p < .000), the 
Relative Advantage condition (Table 3, Model 1: β = -.35, SE =.11, p < .000), and the 
Compatibility condition (Table 4, Model 1: β = -.36, SE =.11, p < .000). These results 
suggest that when an individual has a higher desire for health-related uncertainty, they 
will be less likely to adopt DTC-GT.  
Additionally, the hierarchical regression for the Compatibility group showed that 
that frame exposure led to an increased intent to adopt DTC-GT (Table 4, Model 2: β 
=.11, SE =.11, p < .05). Although this was not hypothesized, as the frame was intended 
to be compatible with one’s privacy concerns through its discussion of data privacy 
standards, it showcases that discussions of privacy standards could affect adoption intent 
overall. Further implications of these main effects, interaction effects, and framing effects 






The goal of Study II was to test hypotheses regarding whether issue-specific 
framing of news articles would have a positive effect on the likelihood of adopting a 
direct-to-consumer genetic test for health information. This study found that there was a 
statistically significant effect of the Absolute Advantage frame on adoption intent. 
Additionally, in the Absolute Advantage frame condition, Desire for Uncertainty had a 
negative interaction effect on the likelihood of adoption as predicted. Lastly, this study 
found Perceived Susceptibility to have a statistically significant interaction in the 
Relative Advantage frame group. The following paragraphs further detail the findings of 
Study II.  
First, the results showed that the only frame with a statistically significant effect 
on adoption compared to the control group as predicted was the Absolute Advantage 
group. The Absolute Advantage frame discussed the testing broadly, giving a succinct 
overview of the pros and cons of the testing without mentioning privacy or comparisons 
to medical provider testing in depth. In contrast, the Relative Advantage article discussed 
the testing broadly and how it compared to a medical provider. The finding of the 
Absolute Advantage framing having a stronger effect on adoption intent reflects prior 
literature in the field of health communication. Past studies have found that, if an 
individual believes an innovation or health-related behavior has benefits or advantages, it 
will be more likely to undergo adoption (Darvishpour, Vajari, & Noroozi, 2018; 
Hochbaum, Rosenstock, & Kegels, 1952). These findings also suggest that, for consumer 




other communication avenues, instead of direct comparisons to a similar innovation may 
be more effective in increasing adoption intent. These framing effects are avenues which 
future research could explore to determine which issues may be most pertinent to 
prospective consumer health innovation customers. 
Second, the study found that, in the Absolute Advantage frame condition, Desire 
for Uncertainty had a negative interaction effect on the likelihood of adoption as 
predicted. This indicates that the effect of Absolute Advantage media framing will be 
weaker for those with a higher desire for health-related uncertainty, leading to a lower 
intent to adopt DTC-GT.  This finding of the interaction effect reflects literature from the 
Theory of Motivated Information Management and how some individuals may prefer 
health-related uncertainty. Prior studies have found that individuals may rather not know 
of their risk of developing a certain condition (i.e., higher desire for uncertainty), as it 
could result in feelings of anxiety or worry, and subsequently avoid seeking out health 
information or engaging with a consumer health innovation (Barbour, Rintamaki, 
Ramsey, & Brashers; 2012; Sairanen & Savolainen, 2010). Therefore, media framing 
may not be as effective for this group of individuals who prefer to remain uncertain about 
their health risk. This could be partially explained by theory around selective perception, 
which argues that individuals will be more likely to view information positively if it is 
congruent with their attitudinal beliefs or expectations (Hwang, 2010; Klapper, 1960). In 
the case of those who prefer to remain uncertain of their health status, persons could 
choose to ignore messages they deem irrelevant or incongruent with their beliefs. As 




their background or beliefs, it is crucial for media strategists to have a strong 
understanding of prospective customers’ prior beliefs around health conditions when 
designing media strategies. 
Third, the last proposed moderator, Perceived Susceptibility, showed a 
statistically significant interaction in the Relative Advantage frame group only. The effect 
of the Relative Advantage frame was not significant in general. This indicates that the 
media framing effect is stronger for individuals with higher Perceived Susceptibility than 
lower Perceived Susceptibility and this finding only partially supports H2C. To further 
understand the Relative Advantage framing effect on those with high and low levels of 
Perceived Susceptibility, two independent samples t-tests were conducted to compare the 
mean adoption intent of those with high and low levels of perceived susceptibility in the 
Relative Advantage and control groups. The groups for the t-tests were divided based on 
the mean score of the Perceived Susceptibility measurement: those who had a higher 
score than the mean for Perceived Susceptibility were placed into the “High Perceived 
Susceptibility” group (first t-test), and those with scores lower than the mean were placed 
into the “Low Perceived Susceptibility” group (second t-test). Those with high levels of 
perceived susceptibility were more likely to adopt DTC-GT when exposed to the Relative 
Advantage frame (M = 3.40, SD = 1.73, N = 50) than if not exposed (M = 2.90, SD = 
1.60, N = 40), but this result was not statistically significant, t(88) = 1.32, p = .19, two-
tailed. Additionally, those with lower levels of perceived susceptibility were less likely to 
adopt DTC-GT when exposed to the Relative Advantage frame (M = 2.50, SD = 1.80, N 




statistically significant, t(98) = 1.32, p = .21, two-tailed. This suggests that, while intent 
to adopt was higher for those with higher levels of perceived susceptibility and exposed 
to the Relative Advantage frame, further research is needed to identify how much of a 
role susceptibility levels can play in affecting framing effects and adoption intent.  
One possible explanation for the interaction effect in the Relative Advantage 
condition only could refer to this frame’s discussion of how DTC-GT offers testing for 
additional conditions compared to in person testing through a medical provider. Perhaps, 
with this further information, those with lower susceptibility levels may have found the 
testing to be irrelevant to their needs. In contrast, those with higher susceptibility could 
have found the testing to be relevant for their health needs. Altogether, these findings 
neither support nor fully contradict prior research on one’s risk perceptions affecting 
health-related behavior engagement (Hochbaum, Rosenstock, & Kegels, 1952; Li et al., 
2003). While literature shows support that one’s assessment of their susceptibility will 
likely affect intent to adopt, this was not found consistently within Study II’s experiment. 
In addition to the main findings, the study also found that Desire for Uncertainty 
showed a statistically significant main effect on the likelihood to adopt DTC-GT across 
the board. In this case, the Desire for Uncertainty showed to have a negative impact on 
adoption intent. This idea of wanting health-related uncertainty supports prior research, 
which has found that individuals may prefer not to know of their risk of developing a 
certain condition, as it could evoke feelings of concern or anxiety (Barbour, Rintamaki, 
Ramsey, & Brashers; 2012; Sairanen & Savolainen, 2010). This research suggests that 




Future research should further examine the strength of Desire for Uncertainty in 
prospective customers’ decision to purchase a DTC-GT. 
While Privacy Boundaries was a proposed moderating variable, it did not have 
any statistically significant moderating effects across any of the conditions as was 
predicted. However, Privacy Boundaries had a statistically significant main effect across 
all framing conditions, and the Compatibility frame showed a main effect on adoption.  
The Compatibility frame focused on the data privacy and security standards of DTC-GT, 
and was tailored to meet the potential needs of those with strong privacy boundaries. 
These findings of Privacy Boundaries and the Compatibility frame showing a main effect 
for adoption intent indicate that individuals' privacy concerns may be such a strong 
determinant of adoption, they should not be encompassed as a moderating variable but as 
a main predictor of adoption independent of the framing effect. Although privacy 
concerns could be within Rogers’ Compatibility attribute, this work suggests that Privacy 
Boundaries should be its own independent predictor for adoption. This research shows 
support for prior research on privacy management which states that health information is 
sensitive and considered confidential (Geer et al., 2001; Petronio & Altman, 2002; Siani 
& Assaraf, 2016; Veach, LeRoy, & Bartels, 2006). As a consequence of this, scholars 
have stated that disclosure or sharing of health information is higher risk than sharing 
other types of information like superlatives (Petronio & Altman, 2002). 
Altogether, this research showed some support for issue-specific framing research 
and key findings from the literature review on motivations and barriers for taking a 




findings, along with those of Study I, will be discussed within Chapter VI: General 






CHAPTER VII: GENERAL RESEARCH CONCLUSIONS AND 
RECOMMENDATIONS 
This chapter will firstly provide a summary of the findings from Study I and 
Study II in a succinct overview. It will then continue to discuss the implications of both 
of the studies for both theory building and industries selling direct-to-consumer genetic 
testing. The chapter concludes with suggestions for future research. 
 
Summary of Study I and Study II 
The overarching goals of this dissertation research included 1) proposing a refined 
model for Rogers’ Theory of Perceived Attributes to meet the consumer health 
innovation environment and 2) to test how issue-specific framing of news articles based 
on the refined model may affect the overall intent to adopt these types of innovations, 
using DTC-GT as a case study. 
 Study I first attempted to refine Rogers’ Theory of Perceived Attributes for the 
direct-to-consumer genetic testing environment. This study was guided by the 
overarching research questions seeking to understand the main motivations and barriers 
to taking a direct-to-consumer genetic test (RQ1 and RQ2). Work from that study showed 
that the biggest motivations for taking a DTC-GT for health included the perceived 
outcomes of testing: receiving valuable health information. Participants expressed they 
would take this health test to gain insight into health information they never knew or did 
not have access to before. Another strong motivation for taking this type of test included 




testing. These expressed benefits included convenience of taking DTC-GT from home, 
the number of reports offered, and the lower price. Lastly, participants also expressed that 
if they felt they were susceptible to the specific health conditions tested for, they would 
be more inclined to purchase DTC-GT. In terms of barriers to taking this test, 
interviewees expressed strong concerns over data privacy and how their health data 
would be used or accessed.  Another barrier to taking the test was the desire for 
uncertainty; some participants stated learning about a health condition could be scary or 
cause them anxiety.  
Study I’s findings were used to inform the adoption framework testing in Study II. 
The second study of this dissertation proposed to investigate the effects of issue-specific 
media framing on the likelihood of adopting a DTC-GT and considered the role of 
moderating variables discovered in Study I. In Study II, it was proposed that exposure to 
issue-specific media frames would lead to a higher likelihood of adopting DTC-GT than 
if not exposed to these frames. A second set of hypotheses predicted that participants’ 
Privacy Boundaries, Desire for Uncertainty, and Perceived Susceptibility would affect the 
relationship between the frame exposure and intent to adopt. The results showed that the 
issue-specific frame with an effect as predicted on adoption was the Absolute Advantage 
article. The Relative Advantage frame did not show to have a statistically significant 
effect on adoption intent. While the Compatibility article had a positive effect on 
adoption intent, this was not predicted for those without high privacy boundaries or 
concerns. For the moderating variables, there were mixed results. Privacy Boundaries did 




significant main effect across all conditions. Desire for Uncertainty had a negative 
interaction of the likelihood of adoption in one frame (Absolute Advantage), but in two 
frames (Relative Advantage, Compatibility) it had a statistically significant main effect. 
Lastly, Perceived Susceptibility only had one interaction effect in the Relative Advantage 
frame condition, but not in the Absolute Advantage group as predicted.  
Altogether, both studies showed that privacy concerns are a strong indicator of 
adoption intent. When individuals are more concerned with their privacy, they will be 
less likely to adopt a consumer health innovation. Additionally, these studies both found 
that the desire for uncertainty regarding health information could be a predictor, but more 
research is needed to confirm whether this should be a moderator or main predictor. 
Furthermore, these studies found mixed results with regard to one's Perceived 
Susceptibility. While Study I found that health risk perception can impact adoption intent, 
this was only statistically significant for one frame within Study II. 
For media framing, this dissertation’s Study II found that the issue-specific 
Absolute Advantage framing and Compatibility framing had a statistically significant 
effect on adoption intent. Those who were exposed to the Absolute Advantage and 
Compatibility frame news articles expressed a higher likelihood of adopting DTC-GT 
than those who were not exposed to this frame. This indicates that the tailoring of media 
messages to discuss the benefits of an innovation and data privacy standards may help 
increase adoption intent of these consumer health innovations. Further research can 
continue to explore which types of media frames and topics are most effective within the 





The aim of this dissertation was to propose a refinement to Rogers’ Theory of 
Perceived Attributes model for the consumer health innovations environment, and to test 
its effectiveness through issue-specific media framing.  Overall, findings from this 
dissertation provided some support for related theoretical frameworks. 
Perhaps the most critical finding of this dissertation was the importance of 
privacy, and how privacy boundaries could largely affect the purchase decision of a 
consumer health innovation. In Study I, which examined main barriers to purchasing 
DTC-GT, interviewees expressed that their privacy and the potential loss of secure 
information would deter them from taking the test. Individuals also expressed concern 
regarding whether their data could be shared with insurance companies and subsequently 
result in higher premiums or denied coverage. This concern and worry of insurance 
repercussions is consistent with prior research’s findings on privacy concerns with 
relation to health insurance (Geer et al., 2001; Siani & Assaraf, 2016). For Study II, 
privacy was also a main factor associated with adoption intent. While Privacy Boundaries 
did not have any interaction effects present as predicted, this variable had a statistically 
significant main effect across all framing conditions. This suggests that one’s privacy 
concerns may be a leading determinant of adoption regardless of media exposure and 
should be considered as a main predictor of adoption of its own, not just within a 
generalized Compatibility variable. Findings from Study I and Study II are also 
consistent with prior research on privacy management which found that many individuals 




Veach, LeRoy, & Bartels, 2006). This concern over privacy is consistent with the ideas 
from the Theory of Communication Privacy Management (Petronio & Altman, 2002). 
From this work, privacy is a leading factor of adoption that should be taken into 
consideration when evaluating the adoption of consumer health innovations. 
Additionally, this dissertation found that the perceived benefits or exposure to the 
“Absolute Advantage” media frame of a consumer health innovation would lead to a 
higher intent to adopt. In Study I, interviewees who thought DTC-GT could provide them 
with valuable health insights reported to be more likely to purchase a test. Study II also 
found perceived benefits to lead to a higher intent to adopt as evident by the impact of the 
Absolute Advantage frame on the likelihood to adopt a DTC-GT. The motivation to take 
a DTC-GT in order to receive “helpful health information” is consistent with research 
from the Health Belief Model, specifically the concept of Perceived Benefits (Hochbaum, 
Rosenstock, & Kegels, 1952) which is named in this study as the Absolute Advantage of 
the technology. Prior research has found that the perceived benefits or the suspected 
positive outcome of a health-related behavior is associated with higher intent of 
engagement (Darvishpour, Vajari, & Noroozi, 2018; Hochbaum, Rosenstock, & Kegels, 
1952). From this dissertation and prior research, the Absolute Advantage of a consumer 
health innovation is an important factor which could affect adoption intent. 
This dissertation also found partial support for the effect of the perceived Relative 
Advantage of a consumer health innovation on adoption intent. In prior literature 
(Rogers, 2003), and in Study I, if an individual thought DTC-GT had benefits compared 




adoption. In Study I, interviewed said they would have an increased intent to adopt DTC-
GT based on how they could take a DNA test and also receive their health results without 
having to drive to a doctor’s office. Furthermore, interviewees believed DTC-GT could 
offer a wider variety of health reports than a medical provider. Lastly, these participants 
assumed DTC-GT would be less expensive than testing through a medical provider. 
These findings are consistent with Rogers’ (2003) Perceived Attributes, specifically 
Relative Advantage, which measures the extent that the innovation is seen to be better 
than what it supersedes (Rogers, 2003). In this case, if potential adopters believe that 
DTC-GT has many “relative advantages” in comparison to testing through a medical 
provider, they will have a higher likelihood of adopting. These findings support research 
from Rogers’ original model for adoption based on his theory of perceived attributes. 
However, this finding was not consistent within Study II. The Relative Advantage frame 
was not effective in predicting adoption intent. Part of this inconsistent effect could be 
due to individuals in this condition not having thought DTC-GT had relative advantages 
compared to testing via a medical provider when reading this article. 
Another insight found was the impact of one’s Desire for Uncertainty regarding 
whether they would have a specific health condition. Study I provided information on 
how one’s desire not to know about health risks could deter prospective customers from 
purchasing DTC-GT. Many interviewees stated they would not want to know if they were 
at an increased risk for cancer or heart disease. These participants expressed it could be 
scary or anxiety-inducing. In Study II, for those in the Absolute Advantage frame 




adoption as predicted. This indicates that the framing effect was weaker for those with a 
higher desire for health-related uncertainty and there was simultaneously a lower 
adoption intent. Altogether this suggests that when one desires a higher level of health-
related uncertainty, they will be less likely to adopt a DTC-GT and could be less 
susceptible to media messaging discussing health technologies. Although Desire for 
Uncertainty did not show an interaction effect in the Relative Advantage condition, it did 
result in a statistically significant main effect on the likelihood to adopt DTC-GT across 
all conditions. In this sense, higher levels of Desire for Uncertainty had a negative impact 
on adoption intent. This desire for uncertainty is consistent with research from the Theory 
of Motivated Information Management. Prior research has found that health-related 
uncertainty may serve as a positive state (Fanos & Johnson, 1995; Lerman et al., 1999). 
Additional studies have noted it is quite common for persons to avoid health information 
to maintain uncertainty (Barbour, Rintamaki, Ramsey, & Brashers; 2012; Sairanen & 
Savolainen, 2010). This concept of the person’s desire for uncertainty serving as a barrier 
to take a DTC-GT is in support of past research regarding information-seeking behavior. 
Resembling the findings with Privacy Boundaries, the findings suggest that Desire for 
Uncertainty may be more effective as a main predictor than a moderator. Further research 
should continue to investigate the importance and strength of Desire for Uncertainty in 
potential customers’ decisions to purchase consumer health innovations. 
Another theoretical implication discovered during was that one’s perception of 
health susceptibility would lead to a higher likelihood of adopting a consumer health 




high cholesterol reported increased intent to adopt. This supports research from the 
Health Belief Model’s Perceived Susceptibility factor, which refers to the person’s 
perception of their risk of acquiring a disease, condition, or illness (Hochbaum, 
Rosenstock, & Kegels, 1952). Other studies have found Perceived Susceptibility to be 
linked with higher engagement in health-related behaviors (Hochbaum, Rosenstock, & 
Kegels, 1952; Li et al., 2003). For Study II, Perceived Susceptibility only showed an 
interaction effect in the Relative Advantage frame group, but not in the Absolute 
Advantage one, indicating the effect of the frame was stronger for those with higher 
perceived levels of health susceptibility. Additionally, this variable only had a 
statistically significant main effect in the Relative Advantage condition, but not the 
Compatibility or Absolute Advantage ones.  This also suggests that a person’s perceived 
likelihood of developing a condition could have a main impact on adoption. However, 
more research is needed to determine if so and how much of an effect. This research 
neither fully contradicts nor supports past work examining one’s risk perceptions 
affecting health-related behavior engagement (Hochbaum, Rosenstock, & Kegels, 1952; 
Li et al., 2003). Although past literature and Study II showed support that an individual’s 
assessment of their own susceptibility will likely affect intent to adopt, this was not found 
within Study II’s experiment. Future research on consumer health innovations can 
continue to investigate the importance of Perceived Susceptibility on adoption intent. 
  This dissertation also showed support for Rogers’ original research on perceived 
attributes. In Rogers’ (2003) model, he states that Compatibility and Relative Advantage 




predictors have less of an impact. This dissertation’s research in Study I and Study II 
support that Relative Advantage would be a top predictor in alignment with Rogers’ 
general model. However, this work did not support past innovation research where 
Trialability, Complexity, and Observability would be important factors in the decision to 
adopt (Coleman et al., 1966; Ford, 2006; Gabbay & le May, 2004, Rogers, 2003). 
Participants in Study I expressed that Trialability, Observability, and Complexity would 
not have much of an effect on their purchase decision, which could be the difference 
between needs for a medical provider and needs for a prospective consumer not using the 
technology for patient care. This shows how there may be differences in adoption criteria 
for each innovation context examined, which Rogers also expresses in his discussion of 
his model (2003). 
For media framing specifically, Study II’s findings showed consistencies with 
prior framing research. The aim of Study II was to test hypotheses concerning whether 
issue-specific framing of news articles would lead to a higher likelihood of adopting a 
consumer health innovation. The findings from Study II indicated that the only frame 
with a statistically significant effect on adoption compared to the control group as 
predicted was the Absolute Advantage group. The difference in the Absolute Advantage 
frame was the omission of comparison to medical providers. While the Compatibility 
frame had a significant effect on adoption intent, this was not predicted nor expected for 
those without high privacy boundaries. The differentiation in this Compatibility frame 
included a further discussion of how companies address data privacy in direct-to-




detail or how it compared to a medical provider. These insights are consistent with ideas 
from prior studies on issue-specific frames. Prior research has found that the strategy of 
incorporating certain detail into an article may affect perceptions of a topic (Kozman, 
2017; De Vreese et al., 2001; Guenduez, Schedler, & Ciocan, 2016), or in this case 
adoption intent. This suggests that, when featuring certain aspects of DTC-GT, such as 
data privacy or the benefits of the testing, adoption may be more likely than if it is not 
emphasized as much. In contrast, Study II also supports prior research in that minimizing 
aspects of a topic, such as transparency of data privacy, can lead to separate outcomes. In 
this case, the minimization of data privacy led adoption to be less likely. Another insight 
from Study II’s work was how the issue-specific framing resulted in different interaction 
effects in the Absolute Advantage and Relative Advantage conditions. For those in the 
Absolute Advantage condition, the framing effect on intent to adopt was stronger for 
those with lower desires for health-related uncertainty (e.g., wanting to know health 
information). In addition, for the Relative Advantage group, Perceived Susceptibility had 
an interaction effect which positively affected adoption intent. This relates to past 
research which states that the salience of certain aspects of an issue in framing could 
affect perceptions around certain topics (Kozman, 2017; De Vreese et al., 2001; 
Guenduez, Schedler, & Ciocan, 2016). This is an area in which future research could 
explore to identify which issues may be most relevant to prospective customers aside 






This section will discuss the limitations for both Study I and Study II. Firstly, 
Study I was a small, exploratory study consisting of twenty Ancestry customers. 
Although this demographic is a target user group for DTC-GT purchasers, with their 
interest in family history and prior purchase of a DNA test for ancestry information, this 
generative study does not have any claims to universality. However, the data from the 
interviews points strongly for trends in user motivations and should be explored further 
and validated. 
Study II was exploratory in proposing and testing a refined technology adoption 
model for DTC-GT. There were both conceptual and methodological limitations of Study 
II. Firstly, one limitation with the experimental design occurred with the statistically 
insignificant manipulation check (p = .07) of the Absolute Advantage frame. This could 
be a result of the control group and the Absolute Advantage framed group articles being 
too similar in terms of stimuli, or an indicator of how Absolute Advantage was measured 
via survey response. Future studies should work to ensure that the manipulation of the 
media framing is significant through additional pretesting. 
A second limitation for Study II occurred when using the platform Qualtrics for 
task-based study design. Although the Qualtrics survey platform has the functionality to 
create task-based experiments, the panelists on Qualtrics who complete these studies are 
not used to task-based analysis. Representatives from Qualtrics have stated that some 
panelists attempt to quickly complete the surveys and will try to bypass lengthy tasks like 




component (Qualtrics, personal communication, April, 2020). This limitation became 
evident when analyzing the raw survey data, which showed how many times participants 
tried to click past the article screen to skip straight to answering the survey questions. 
An additional limitation occurred with the lower internal consistency of the 
Relative Advantage measure (Cronbach’s α = .64). There are potential explanations for 
why this score may be lower. For instance, the low internal consistency could be related 
to differences in how participants may have conceptualized a “relative advantage” in 
genetic testing technology compared to testing via a medical provider. As an example, 
some participants could have rated DTC-GT differently throughout the measures (e.g., 
convenience, cost) based on the factors or domains they found to be the most important. 
If a participant thought cost was a determining factor for adoption, but not the amount of 
conditions offered, a participant would have in turn an inconsistent relative advantage 
score. 
Other limitations include the mutual exclusivity of categorizations of motivations 
and barriers for adoption, confounding variables within the news articles shown to 
participants, and the potential of perceived bias in one of the articles. Each of the framed 
news articles varied in terms of length and number of quotes, with the Relative 
Advantage frame having more quotes than the other conditions and being longer overall. 
Additionally, the Relative Advantage frame could have provoked participants’ thoughts 
regarding the intention of the article. While efforts were made to make the news articles 
neutral through pretesting of content, the comparisons to a medical provider within the 




 The research in Study II also resulted in a number of unsupported findings. One 
possible explanation for the unsupported findings of the hypothesized effects could be the 
stimuli used within Study II. The news articles were intended to be more neutral, and, as 
a result, the non-persuasive nature of some of the articles could have had an arguably 
smaller effect on adoption intent than more persuasive stimuli such as an advertisement. 
Future studies could address this by testing the effect of advertisements and other types of 
persuasive media content. 
Another limitation occurs with the Diffusion of Innovations theory as a whole, 
and how it does not foster a participatory approach to adoption. DOI does not take into 
account individuals’ resources or social support to adopt a new technology, which could 
in turn have an effect on intent. For example, a person could hear about a new technology 
through multiple channels or not have social support pertinent to adoption. Further 
studies can work to implement potential adopters’ social support and resources into their 
diffusion research. 
 
Directions for Future Research 
There are many possible avenues future studies could pursue to address the 
findings from this dissertation, as well as the limitations of this work. From a theoretical 
perspective, future work could run a large-scale quantitative study comparing Rogers’ 
original model to the proposed one. While the first study of this dissertation sought to 
narrow down and propose a refined model, the scope was small and qualitative (N = 20). 




provide exploratory insight into which factors would have the strongest combined 
predictive power for adoption intent. This route for research would further test Rogers’ 
theory for the consumer health environment. 
Further research considering framing effects specifically can consider other forms 
of communication media aside from news articles that prospective customers may be 
exposed to in a real-life scenario. While Study II examined the framing effects of news 
articles specifically, other research could consider strategic marketing such as 
advertisements which detail participants’ perceived benefits of the testing for example. 
This employment of a traditionally more strategic and persuasive communication 
approach could also help address the failed manipulation check of the Absolute 
Advantage frame. 
Another avenue for prospective research could entail research comparing specific 
customer segments, such as how Rogers’ classified early adopters versus the late 
majority. Research can analyze whether the needs per adopter categories shift or remain 
constant (e.g., is Relative Advantage as strong of a proposed predictor across all types of 
adopter groups?). This could entail in-depth customer and prospective customer 
interviews, or employ a survey targeting these groups specifically. 
Alongside customer segments, additional avenues for research could examine 
equity or disparities in access to DNA information and emerging consumer health 
innovations. While scholars have discussed new technologies as striving for increased 
access to healthcare (Suennen, 2018), researchers have found that there are racial and 




topics (Peters, Rose, & Armstrong, 2004; Smedley, Stith, & Nelson, 2003; Suther & 
Kiros, 2009). Future studies could conduct in-depth user interviews with different racial 
and ethnic groups to further understand these disparities within the context of genetic 
testing and gain insight into addressing this gap. 
It would also be beneficial to examine users’ experience going through a medical 
provider compared to testing through a DTC-GT service. While participants in Study I 
expressed it would be “convenient” and “beneficial” to be able to quickly get DNA 
results and perhaps have a higher number of results from DTC-GT, they may not receive 
the aspect of psychosocial counseling and support involved with genetic counseling, or 
testing via medical provider (Uhlman, Schuette, & Yashar, 2009). In addition, they may 
not have a medical provider to cover the DNA testing results and their implications in 
depth (Uhlman, Schuette, & Yashar, 2009). In DTC-GT, it is not always common for the 
customer to have contact with a medical provider (FDA, 2009). Further studies can 
perhaps include a diary study of individuals going through medical testing via provider 
and DTC-GT service for direct comparisons to further understand and contrast the 
differences between the experiences. 
 
Recommendations for Industry / Consumer Health Technology Companies 
This section provides relevant suggestions for companies within the direct-to-
consumer genetic testing industry based on the research. The results from Study I and 
Study II showed that an individual’s privacy boundaries can have a strong influence on 




and upfront data privacy standards, stating it would affect their decision to purchase. 
Study II also showed that privacy was a strong predictor for adoption, regardless of 
assigned condition. Companies offering DTC-GT should ensure that their data privacy 
standards are transparent at the point of purchase, so customers can make more informed 
decisions based on their expressed needs. 
From Study II, it is also important to draw on the users’ listed motivations related 
to Perceived Benefits and Perceived Susceptibility, which seem to correlate with early 
health detection and family health planning. This could include marketing to the 
prospective customers in ways such as “find out information that may be useful to your 
family” or a similar pitch. Media communication specialists and marketers can 
strategically implement these messages into their advertisements in efforts to increase 
adoption interest and intent. 
 
Concluding Statement 
 As a whole, this dissertation attempted to shed light on factors that might affect 
the likelihood of adoption for emergent consumer health innovations, specifically direct-
to-consumer genetic testing for health information. Informed by Rogers’ Theory of 
Perceived Attributes and theory regarding health behavior engagement and information-
seeking behavior, this dissertation discovered some of the main motivations and barriers 
to adoption. These factors include the desire to receive previously unknown health 
information, confirming a known health history, and the ability to take proactive health 




susceptibility, and the cost of the test. Considering the upward rise of DTC-GT in market 
forecasts (Lipsman, 2019; HIMSS, 2019; Medium, 2018; Suennen, 2018), it is beneficial 
for technology companies to take advantage of this motivation and address barriers to 
increase adoption intent among customers.  
Another main finding from Study I and Study II of this dissertation was the 
importance of addressing prospective customers’ privacy concerns. In both studies, 
privacy concerns were an ultimate concern and barrier to taking a DTC-GT. Companies 
should consider how they propose privacy policies to customers to ensure they are giving 
customers a holistic view of how their data would be used or shared.  
Another key insight from this work was the power of issue-specific media 
framing on intent to adopt, and how slight framing changes of a news article could lead to 
an increased likelihood of adoption or provoke certain thoughts about an innovation. For 
example, highlighting the benefits of the technology as within the Absolute Advantage 
condition showed an increase in adoption intent. This research supports past work from 
scholars on media framing, which has found that exposure to a media framed message is 
generally correlated with an increased intent to partake in a specific behavior (Gross, 
2008; Rodrigue et. al, 2014; Schuk & de Vreese, 2006). Additionally, this dissertation 
found how individual differences could affect adoption intent and the strength of media 
framing effects. For example, in the Absolute Advantage frame condition, Desire for 
Uncertainty had a negative interaction effect on the likelihood of adoption as predicted. 
This indicates that the effect of media framing was weaker for those with a higher desire 




Advantage group, the framing effect was stronger for those who had a higher Perceived 
Susceptibility. Scholars can continue to examine the effect of exposure to media frames 
and possible interaction effects.
In conclusion, the research within this dissertation made contributions to the 
Rogers’ Theory of Perceived Attributes and Media Framing theory. Firstly, this 
dissertation proposed a framework for analyzing user perceptions of consumer health 
innovations based on the refinement of Rogers’ criteria through relevant literature and 
prospective customer interviews. Review of relevant theoretical literature and findings 
from Study I began to refine Rogers’ attributes for the consumer health innovation 
environment and showed that prospective adopters valued data privacy, the perceived 
benefits of an innovation, and how the innovation compared to prior offerings. Secondly, 
this dissertation contributed to media framing literature in terms of the effect of framing 
consumer health innovations. This work found that the framing of a news article could 
impact adoption intent, specifically when discussing the benefits of a technology or its 
privacy standards. This dissertation also found that framing effects can vary for different 
groups of people, as the framing effects were stronger for those with higher levels of 
perceived susceptibility and lower levels of desire for uncertainty. This has implications 
for journalists to understand how their news articles may be understood, and suggestions 
for strategic communication specialists for determining which content may help increase 
adoption intent and for which group of people. Overall, this research proposed a 
framework for consumer health innovation adoption that can be built upon and further 





Study I: Interview Protocol 
[Introduction]  
Hi! My name is Brittany, and I am calling from Ancestry, may I speak with [name] 
please? 
 
I am calling in regards to a survey you took that you’d be interested in participating in a 
phone interview with us today? [Wait for response] Great! This research project 
specifically is to explore individuals’ thoughts on specific aspects of DNA testing. As a 
thank you for your time today, we’d send you a $50 Amazon gift card to your email 
address.  
 
Before we get started, could I have you review and sign a participant and consent form 
for me please? I can send that directly to your email that you provided on the survey. 
● *Email consent form which is the link to Qualtrics and give participants time to 
review and sign* 
 
After consent: Thank you so much for agreeing to participate in our study. Again, the 
goal of our work is to better understand potential motivations and barriers to DNA 
testing. In this conversation today, we will focus specifically on testing for health 
information.  
 
We’ll spend the next 45–60 minutes discussing your thoughts and perceptions of this type 
of testing. The information you provide will help us better understand potential barriers 
to this type of testing. If at any time you wish to stop participation, please let us know and 
we will stop the interview.  
 
 
[General Perceptions of DTC Genetic Testing] 
I’d like to start off by asking you a few questions on your opinion of DTC genetic testing 
for health. 
● Have you ever heard of DTC genetic testing for health? 
○ If yes, could you tell me a little bit about what you know? About the 
process? What kind of information can it provide? 
○ If no, this type of testing can provide you with health information, 




developing or at risk for. This could include specific cancers or 
intolerances. 
● What are your general thoughts on DTC genetic testing? 
● Have you ever taken a DTC genetic test for health (or do you know anyone who 
has taken the test such as a family member)? 
○ Why or why not? 
○ If yes, could you tell me a little bit about that experience, please? 
○ If no, would you be interested in taking the test? Why or why not? How do 
you think the information provided could be useful or not useful?  
● Have you ever taken a DNA test for ancestry information? 
○ If yes, ask why one and not the other* 
 
[Motivations] 
In this next section, I’d like to consider what would motivate you to take a DTC genetic 
test for health information. 
● What would motivate you to take a DTC test for health information? 
● Can you tell me about a scenario in which you would take this type of test for 
health information? 
○ If no ideas, prompt with the following: 
○ Ruling out a specific condition? (Susceptible to specific cancers) 
○ Family history? 
○ Would convenience be a factor? Would DTC genetic testing be more 
convenient than going to a doctor? 
○ Type of sample – Saliva vs. blood? 
○ What about how insurance is not required to take the DTC test? 
○ Multiple tests offered? 
 
[Barriers] 
In this next section, I’d like to consider what would prevent you from taking a DTC 
genetic test for health information. 
● What concerns would you have before taking a DTC test for health information? 
● Would you want to know if you had a specific condition? Or would you rather not 
know? 
● What potential reservations/concerns would you have before taking this type of 
online test compared to through a doctor in-person? 
 
[Privacy] 




● In general, do you feel comfortable sharing information with other people? Does 
it vary by topic?  
● What about offline versus online? Such as social media? 
● Would you feel comfortable sharing this type of health information (having it 
stored in an online system?) 
○ Who do you think would have access to it? 
● Would you be interested in sharing your health results with family? Friends? 
Would you compare results with anyone? 
 
[Evaluation of Test Output] 
● What are your thoughts on the accuracy of these testing results? Collecting a 
DNA sample (often saliva) to produce health information. 
● Would you trust results from an online system? Or would they rather see a doctor 
in person to get health information? Would you go through follow-up testing with 
your doctor if you had a positive result? 
● How useful do you think these results would be? 
● What information do you think this type of test is lacking? Specific conditions? Is 
there anything you would want to be specifically included in the test? 
 
[Closing/Wrap Up] 
● If you had to sum up the most important factor which would lead you to take this 
type of test or one that would prevent you from taking this type of test, what would 
that be? 
● Those were all of the questions I had for you today! I just wanted to check in and 
see if there were any additional comments you have on DTC genetic testing? 
● Thank you again for participating! We greatly appreciate your time and insight. 
We will be sending the Amazon gift card to your email. I am just going to confirm 
your email address. 
 
Study I Coding: A Priori Codes and Refinement 
Includes a list of a priori codes based on relevant literature to begin analysis before 
modifying / revising for emergent themes, or themes not brought up in the interviews 
(Diffusion of Innovations/Perceived Attributes, Communication Privacy Management, 
Health Belief Model, Theory of Motivated Information Management) 
 
List of a priori codes alongside their relevant variables from the literature: 
1. Diffusion of Innovations (Rogers) 




○ Early adopters (no convincing before testing out) 
○ Early majority (evidence before adoption, but early group) 
○ Late majority (skeptical of testing, adopting after updates made/refinement 
in accuracy) 
○ Laggards (haven’t taken DNA test at all) 
2. Theory of Perceived Attributes (Rogers) 
○ Comparison to medical testing through health provider (relative 
advantage) 
○ Seen sample reports (trialability) 
○ Friend/family use of test (observability) 
○ Understanding of DTC-GT offerings (complexity) 
○ Belief in DNA testing (compatibility) 
3. Communication Privacy Management (Petronio) 
○ Data privacy concerns (privacy boundaries) 
○ Ownership of health data (information ownership) 
○ Trust in online system (recipient evaluation) 
○ Perceived security of data (privacy boundaries) 
4. Health Belief Model (Hochbaum, Rosenstock, and Kegels) 
○ Opinion of conditions tested (perceived severity) 
○ Family history of condition (perceived susceptibility) 
○ Cost of test (perceived barriers) 
○ Knowledge of test offerings (perceived benefits) 
○ (cue to action) 
○ Able to purchase test (e.g., cost of test) (self-efficacy) 
5. Theory of Motivated Information Management (Afifi and Weiner) 
○ Unknown health history (uncertainty discrepancy) 
○ Belief in test accuracy (target efficacy) 
○ Trust in results from an online system (target honesty) 
○ Not wanting to know positive results (coping efficacy) 
 
Coding Revision Plan 
Initial Stages 
● BA and DW to code 5 interview transcripts (same interviews) based on the list of 
a priori codes above. 
● After coding 5 interviews, BA and DW will meet and refine/identify emergent 
themes in transcripts. 
● BA + DW code 2 more transcripts each to see if other themes emerge or need to 
be modified. 
 
Reaching Saturation Point 
● BA and DW meet to decide on the final coding scheme based on themes present 




● BA and DW recode original 5 interviews together with final scheme to determine 
intercoder reliability. 




Control Group Article Plain Text (Base Article for All Conditions) 
Direct-to-consumer genetic testing (DTC-GT) for health information has grown in 
popularity this year, showing a large increase in sales since the beginning of 2019. DNA 
testing companies promise customers a variety of different results, ranging from cancer 
risk assessments, carrier statuses for conditions like Cystic Fibrosis, and even nutritional 
and wellness information.  
 
After taking a DNA test, customers will find out their health risk for certain conditions, 
and whether it is above, below, or average compared to typical risk levels. 
 
“For cancer risk, many DTC-GT companies offer testing for breast cancer, ovarian 
cancer, uterine cancer, colon cancer, melanoma, pancreatic cancer, and stomach cancer,.” 
says Dr. Lance Clements, chief medical officer at Novartis.  
 
Excluding cancer predisposition, the most commonly included medical conditions these 
DTC-GT services test for include celiac disease, Alzheimer’s disease, Parkinson’s 





In addition to health risk, DTC-GT services offer wellness information. These tests 
provide results for one’s lactose tolerance, caffeine metabolism, or reactions to alcohol. 
 
“Altogether, these testing services aim to provide customers with a picture of their health 
for proactive health actions, preventative measures, and family planning purposes,” says 
Dr. Clements. 
 
While these offerings promise customers information regarding their health risk, experts 
urge consumers to keep the limitations of the testing in mind both pre-purchase and when 
reviewing their results. 
 
“These consumer genetic tests are limited by the amount of variants they look for; they 
do not look at every gene mutation linked to specific diseases,” says Dr. Leigh Atwood, 
geneticist at Lakeview’s Children’s Hospital, “if a customer gets a ‘negative result’ for 
breast cancer risk, this does not eliminate the possibility of developing cancer.” 
 
Dr. Atwood urges all consumers to follow-up with a medical provider, such as a 
physician or genetic counselor, to further explain the implications of their testing results. 
 
“This type of testing cannot tell definitively whether someone will or will not get a 





Absolute Advantage Article Add-On Plain Text 
For a breakdown of the testing process, it begins with the customer purchasing a DNA 
testing kit from a company online, which can cost anywhere from $100–$200.  
 
“I always had an assumption that genetic testing would cost thousands of dollars,” says 
Roger Atwood, a recent 23andMe customer, “the pricing of the direct-to-consumer test 
was very affordable for my budget.” 
 
Since these tests are from direct-to-consumer companies, customers do not need a 
doctor’s referral for testing nor go through health insurance to purchase the test. 
 
After receiving the kit, the customer then submits a small saliva (spit) sample to the 
company and waits for their results to be analyzed.  
 
About 2–3 weeks later, health report results are delivered to the customer on the 
company’s website. 
 
“The testing and results process was convenient and easy,” says Ancestry DNA test 
customer, Angela Smith, “I was able to view the results from the comfort of my home; I 





The number of reports available depends on the company, but a standard DNA test for 
health information can provide results for about 150 conditions. 
 
“Individuals getting testing from a direct-to-consumer service will have a wide range of 
test results available to them, but the testing won’t be personalized based on their 
background.” says Dr. Thomas O’Brien, a geneticist at West Hyland Hospital. “It’ll be 
important for consumers to read through each company’s test offerings before purchase 
to see if the testing would be applicable to them.” 
 
Relative Advantage Article Add-On Plain Text 
For a breakdown of the testing process, it begins with the customer purchasing a DNA 
testing kit from a company online, which can cost anywhere from $100–$200. DNA tests 
from a medical provider range from $100 to upwards of $2,000 depending on the specific 
tests needed. 
 
Since these tests are from direct-to-consumer companies, customers do not need a 
doctor’s referral for testing nor go through health insurance to purchase the test. 
 
“I would never have been able to afford testing through my medical provider, which was 
estimated at almost a thousand dollars,” says Roger Atwood, a recent 23andMe customer, 
“the pricing of direct-to-consumer test was about 1/3 of the cost of getting testing from 




After receiving the kit, the customer then submits a small saliva (spit) sample to the 
company and waits for their results to be analyzed. While some hospitals may require 
blood samples for DNA testing, most direct-to-consumer company tests only require a 
saliva sample. 
 
About 2–3 weeks later, health report results are delivered to the customer on the 
company’s website. 
 
“The testing and results process was convenient compared to going through my medical 
provider,” says Ancestry DNA test customer, Angela Smith, “I was able to view the 
results from the comfort of my home; I didn’t have to go to my doctor to find out my 
results or to submit a DNA sample.” 
 
The number of reports available depends on the company, but a standard DNA test for 
health information can provide results for about 150 conditions. 
 
“DNA testing through a medical provider is very much tailored to the individual patient 
and only looks at specific conditions based on the patient’s family history or current 
medical concerns,” says Dr. Thomas O’Brien, a geneticist at West Hyland Hospital. 
“Individuals getting testing from a direct-to-consumer service will have a wider range of 
test results available to them, but the testing won’t be personalized based on their 




offerings before purchase to see if the testing would be applicable to them.” 
 
It is important for consumers to note that, while these DTC-GT services provide a much 
larger number of reports than tests through a medical provider, which typically only test 
for a few conditions at a time, the DTC-GT conditions tested are not tailored to the 
individual or based off of their family history. 
 
For customers looking to find out information on a specific or very rare condition, it is 
important to check whether the DNA test company offers testing for the condition, or 
consult with a medical provider. 
 
Compatibility Article Add-On Plain Text 
While DNA testing has been used in medical and scientific contexts for decades, direct-
to-consumer testing kits are still relatively new and legal policies that govern the private 
use of consumer data are still being developed. 
 
In order to make sure their DNA data is safe, it is important for customers to review a 
DNA company’s privacy policy and learn how to control who could access their data. 
 
“These privacy policies cover all of the data the company could collect, how it’s used, 
and how consumers can control their own data,” says Melissa Danielson, Google’s lead 




print on policies.” 
 
Companies will ask customers to give or deny consent to data storage and third-party use, 
giving them control over what can be shared. The permission to allow the DNA testing 
company to store a sample means that a company can go back and test it again if more 
advanced techniques are developed in the future. Sharing with a third-party can entail 
medical research or marketing. 
 
“If a customer gives a company permission to share their data with another organization, 
they can always revoke that permission later.” says Danielson.  
 
Reputable companies will make sure to inform customers as much as possible about 
privacy and data usage, but customers should be aware and thoroughly read privacy 






Full models: All hypothesized moderator interactions simultaneously factored 
Table 5. 
Hierarchical Regression Results for Exposure to the Relative Advantage Frame on 
Intent to Adopt DTC-GT. 
 Model 1 Model 2 Model 3 
Block 1 – Baseline Model    
Age -0.23** -0.24*** -0.23** 
Race (White/Non-White) -0.09 -0.09 -0.09 
Gender -0.13* -0.14* -0.15* 
Education 0.14* 0.15* 0.15* 
Income 0.01 -0.00 -0.00 
Previous DNA Test -0.08 -0.09 -0.09 
Privacy Boundaries -0.20** -0.19** -0.20* 
Desire for Uncertainty -0.35*** -0.36*** -0.33** 
Perceived Susceptibility 0.18** 0.18** -0.04 
Block 2 – Frame exposure    
Exposure to RA Frame  -0.05 -0.04 
Block 3 – Interaction terms    
RA Frame X Privacy   0.00 
RA Frame X Desire for 
Uncertainty   -0.05 
RA Frame X Perceived 
Susceptibility   0.22** 
R² 0.40 0.40 0.43 
ΔR² 0.37 0.37 0.39 
Note: ᵗp < .1. * p <; .05. ** p < .01. *** p < .001. 
Cell entries are final-entry OLS standardized coefficients (β). N = 190 





Hierarchical Regression Results for Exposure to the Absolute Advantage Frame on 
Intent to Adopt DTC-GT. 
 Model 1 Model 2 Model 3 
Block 1 – Baseline Model    
Age -0.15** -0.14* -0.13 
Race (White/Non-White) -0.02 -0.03 -0.04 
Gender -0.24*** -0.25*** -0.25 
Education -0.06 -0.05 -0.07 
Income 0.16* 0.17* 0.18 
Previous DNA Test -0.10 -0.10 -0.09 
Privacy Boundaries -0.17** -0.17** -0.23 
Desire for Uncertainty -0.42*** -0.41*** -0.28 
Perceived Susceptibility 0.07 0.07 0.06 
Block 2 – Frame exposure    
Exposure to AA Frame  0.13* 0.13* 
Block 3 – Interaction terms    
AA Frame X Privacy   0.07 
AA Frame X Desire for Uncertainty   -0.19* 
AA Frame X Perceived 
Susceptibility   0.01 
R² 0.47 0.49 0.51 
ΔR² 0.44 0.46 0.47 
Note: ᵗp < .1. * p <; .05. ** p < .01. *** p < .001. 
Cell entries are final-entry OLS standardized coefficients (β). N = 190 





Full Survey with Logic 
Start of Block: Introduction Agreement 
  
Q1 This opinion survey is intended to collect information from individuals that will be used in a 
research project to gain a deeper understanding of consumer health information platforms.  You 
will first be shown a news media article on DNA testing and then asked to answer opinion 
questions about the article and DNA testing. Questions will revolve around your preferences for 
new health technologies and technology adoption in general. The entire survey will take 
approximately 10–15 minutes to complete and your participation is entirely voluntary. You must 
be at least 18 years old to participate in this study. The survey does not ask for personally 
identifying information, so your answers will not be linked to you. The researchers will store your 
survey responses in a password protected, encrypted Google drive owned by the researcher which 
requires VPN to access. Your responses will be made available to Ancestry.com, but they will not 
be able to identify you from your answers. The results of the opinion survey and corresponding 
analysis may be published in a scientific journal, but any data stemming from the survey and 
analysis will be aggregated and will not include identifying information, meaning that none of the 
answers you provide will be identifiable to you. Potential risks for partaking in this study include 
loss of confidentiality and discomfort answering questions. If you are uncomfortable answering 
any of the questions, you can skip them or withdraw from the study altogether at any time. If you 
decide to withdraw from this study, the information that you have already provided will be stored 
in the Google drive, but will not be used further in the analysis and will be deleted once the study 
is complete. Your participation in the study may contribute to the field of communication in 
furthering our understanding of how individuals evaluate emerging health platforms. You as a 
subject will receive no benefits from participating in the study.  For more information about the 
research, please contact The Principal Investigator of this study, Brittany Andersen, User 
Experience Researcher at Ancestry and PhD Candidate and student at Boston University at 
bla@bu.edu, or Dr. Lei Guo, Professor at Boston University/Research Faculty Advisor, at 
guolei@bu.edu.  You may also contact the Boston University Institutional Review Board at 
irb@bu.edu or 617-358-6115. 
o I have read the information in this consent form including risks and possible benefits and I 
agree to participate in the study.  (1) 
o I DO NOT agree to this participation agreement  (2) 
  






Start of Block: Screener Qs 
  





Q27 What is your gender? 
o Male  (1) 
o Female  (2) 
o Prefer not to answer  (3) 




Q14 Have you ever taken a DNA test for health information through a company? 
o Yes, through AncestryHealth  (6) 
o Yes, through 23andMe  (1) 
o Yes, through Color  (2) 
o Yes, through Helix  (3) 
o Yes, through another company  (4) 
o No, I have never taken a direct-to-consumer test for health information through a company  
(5) 
  
End of Block: Screener Qs 
  
Start of Block: Stimuli Introduction 
  
Q56 You will be asked to read a news article on DNA testing for 3–5 minutes. You have to 
remain on the article for at least 3 minutes before you can progress to the survey questions. When 
you're ready to read the article, please click to the next question. Once 3 minutes have passed on 
the news article page, you will be able to progress. You may zoom in or out to view the article 
better. Please continue to the next question to read the article. 
  





Start of Block: Control Group 
Start of Block: Absolute Advantage  
Start of Block: Relative Advantage 
Start of Block: Compatibility 
[Randomized which article is shown] 
  
Start of Block: Theory Questions 
  
Q7 We'd now like to ask you some questions on direct-to-consumer genetic testing and its 
offerings. Please read and respond to the following statements: 
























to specific health 
conditions. (1) 
o   o   o   o   o   o   o   
I think this type of 
genetic health test 
can provide useful 
information for 




o   o   o   o   o   o   o   
I think this type of 


















to specific health 
conditions. (4) 








Q39 Please indicate the extent to which you agree or disagree with the following statement: 






































Q38 Please read and respond to the following statements about direct-to-consumer genetic testing 
compared to testing through a doctor: 



















I think taking a 
direct-to-
consumer genetic 
test for health is 
more convenient 
than going 
through my own 
doctor. (1) 
o   o   o   o   o   o   o   
I would rather 
get all health 
testing done by 
my own doctor. 
(2) 








testing through a 
company. (3) 
o   o   o   o   o   o   o   
I think taking a 
direct-to-
consumer genetic 
test is less 
expensive than 
going through 
my doctor. (4) 
o   o   o   o   o   o   o   
I think direct-to-
consumer genetic 
testing has many 
advantages over 
testing with my 
doctor. (5) 
o   o   o   o   o   o   o   
  
  





Q54 Please indicate the extent to which you agree or disagree with the following statement: 































o   o   o   o   o   o   o   
  
  
Page Break   
 
  
Q52 Please read and respond to the following statements: 


















I feel that direct-
to-consumer 
genetic testing is 
compatible with 
my health needs. 
(1) 





provide me with is 
valuable. (2) 




I would feel 
comfortable 







o   o   o   o   o   o   o   
Direct-to-
consumer genetic 
testing is an 
effective way for 
me to receive 
personal health 
information. (4) 
o   o   o   o   o   o   o   
  
  
Page Break   
 
  
Q55 Please indicate the extent to which you agree or disagree with the following statement: 


















I am concerned 







o   o   o   o   o   o   o   
  
  






 Q56 Please indicate the extent to which you agree or disagree with the following statement: 


















I believe that a 
direct-to-
consumer service 
will protect my 
health data. (1) 
o   o   o   o   o   o   o   
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Q40 Please read and respond to the following statements: 


















In general, it would be 
risky to give personal 
information to this 
direct-to-consumer 
genetic testing service. 
(1) 
o   o   o   o   o   o   o   
There would be high 
potential for privacy 
loss associated with 
giving personal 
information to this 
direct-to-consumer 
genetic testing service. 
(2) 






testing service. (3) 












o   o   o   o   o   o   o   
I am concerned that 
the information I 
submit to this direct-
to-consumer genetic 
testing service could 
be misused. (5) 
o   o   o   o   o   o   o   
I am concerned that 
others can find private 
and personal 
information about me 
from this direct-to-
consumer genetic 
testing service. (6) 
o   o   o   o   o   o   o   
I am concerned about 
providing personal 
information to this 
direct-to-consumer 
genetic testing service 
because it could be 
used in a way I did not 
foresee. (7) 
o   o   o   o   o   o   o   
  
  







Q41 Please read and respond to the following statements: 


















I want to know if I 







o   o   o   o   o   o   o   
I would take a 
direct-to-
consumer genetic 
test to rule out if I 







o   o   o   o   o   o   o   
I would rather not 
know if I am at an 
increased risk for 
a specific health 
condition. (3) 
o   o   o   o   o   o   o   
I would only take 
a direct-to-
consumer genetic 
test if I already 
knew that I was at 
risk for a specific 
health condition 
(e.g., if a specific 
cancer ran in my 
family). (4) 
o   o   o   o   o   o   o   
  
  




Q42 Now we'd like to ask you questions on inherited health conditions. Please read and respond 
to the following statements: 


















The possibility that I 
am at risk for a health 
condition (e.g., cancer, 
high cholesterol, or 
Alzheimer’s disease) 
is very high. (1) 
o   o   o   o   o   o   o   
The possibility that I 
will have a serious 
health condition 
develop (e.g., cancer, 
high cholesterol, or 
Alzheimer’s disease) 
in a few years is very 
high. (2) 
o   o   o   o   o   o   o   
I feel that I will have a 
health condition 
during some part of 
my life (e.g., cancer, 
high cholesterol, or 
Alzheimer’s disease). 
(3) 
o   o   o   o   o   o   o   
I fear dying of an 
inherited health 
condition (e.g., cancer, 
high cholesterol, or 
Alzheimer’s disease). 
(4) 
o   o   o   o   o   o   o   
In comparison to a 
peer, the possibility 
that I have an 
inherited health 
condition (e.g., cancer, 
high cholesterol, or 
Alzheimer’s disease) 
is very high. (5) 
o   o   o   o   o   o   o   
  
  




 Q43 Please read and respond to the following statements: 




























o   o   o   o   o   o   o   
I am unsure 







o   o   o   o   o   o   o   





for health. (3) 
o   o   o   o   o   o   o   
I do not know 
how direct-to-
consumer 
genetic testing is 
different from 
going to see a 
doctor for health 
testing. (4) 
o   o   o   o   o   o   o   
  
  






Q44 Please read and respond to the following statements: 


















I prefer to test out 
a new health 
technology before 
committing to a 
purchase. (1) 
o   o   o   o   o   o   o   
Being able to view 
sample health 
reports would be 
important in my 
decision to take a 
direct-to-
consumer genetic 
test for health. (2) 
o   o   o   o   o   o   o   
I would not 
purchase a direct-
to-consumer 
health test unless I 
could view sample 
reports 
beforehand. (3) 
o   o   o   o   o   o   o   
I would look at 
sample health 






o   o   o   o   o   o   o   
  
  
Page Break   
 




Q45 Please read and respond to the following statements: 


















I will only adopt a 
new health-related 
technology or 
service if I know 
that it has been 
used successfully 
by others. (1) 
o   o   o   o   o   o   o   
I know of a friend 
who has taken a 
direct-to-
consumer genetic 
testing for health 
information. (2) 
o   o   o   o   o   o   o   
I know of a family 
member who has 
taken a direct-to-
consumer genetic 
testing for health 
information. (3) 
o   o   o   o   o   o   o   
I have heard of 
direct-to-
consumer genetic 




o   o   o   o   o   o   o   
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Q50 Please read and respond to the following statements: 


















I would allow my 
health insurance 
to access my 
direct-to-
consumer genetic 
test results. (1) 
o   o   o   o   o   o   o   
I worry about my 
health insurance 
company gaining 
access to my test 
results. (2) 
o   o   o   o   o   o   o   
I would feel 
comfortable 
having my health 
information stored 





o   o   o   o   o   o   o   
If I took a direct-
to-consumer 
health test, I 
would worry 
about who has 
access to my 
health 
information. (4) 
o   o   o   o   o   o   o   
I feel comfortable 
sharing 
information about 
myself online. (5) 
o   o   o   o   o   o   o   
  
  





 Q46 Now we'd like to ask your preference on sharing health testing results. Please read and 
respond to the following statements: 


















I would like to 
share my health 
test results with 
my family. (1) 
o   o   o   o   o   o   o   
I would like to 
share my health 
test results with 
my friends. (2) 
o   o   o   o   o   o   o   
I would like to 
share my health 
test results with 
my doctor. (3) 
o   o   o   o   o   o   o   
I would like to 
share my health 




o   o   o   o   o   o   o   









o   o   o   o   o   o   o   
  
  







Q29 Please choose “none of the above” from the list below. 
o Every day  (1) 
o Once a week  (2) 
o Once a month  (3) 
o Never  (4) 
o None of the above  (5) 
  
End of Block: Theory Questions 
  
Start of Block: Online News 
  
Q48 How often do you get news from the following traditional media sources?  
  Never (1) Rarely (2) Sometimes 
(3) 
Often (4) Always (5) 
Printed 
newspaper (1) o   o   o   o   o   
Printed news 






o   o   o   o   o   







Q49 How often do you get news from the following online media platforms?  
Note: The following questions are about how you get news. If you use the following media but 
not to get news (e.g., you may use YouTube for entertainment only), please select "Never" in this 
category. 
 
  Never (1) Rarely (2) Sometimes 
(3) 
Often (4) Always (5) 
Online news 






e.g., blogs)  
(2) 
o   o   o   o   o   
Facebook  (3) o   o   o   o   o   
Twitter  (4) o   o   o   o   o   
Reddit  (5) o   o   o   o   o   
YouTube  (6) o   o   o   o   o   
Snapchat  (7) o   o   o   o   o   
Printed news 
magazine  (8) o   o   o   o   o   
News app  (9) o   o   o   o   o   
Other (Please 





Q50 How often do you get news online? 
o Never  (1) 
o Rarely  (2) 
o Sometimes  (3) 
o Often  (4) 
o Always  (5) 
  
End of Block: Online News 
  
Start of Block: DNA Testing and Intent to Take Test 
  
Q4 Have you ever taken a DNA test for ancestry information? 
o Yes, through Ancestry  (1) 
o Yes, through 23andMe  (2) 
o Yes, through MyHeritage  (3) 
o Yes, through another company  (4) 
o Never taken a DNA test for ancestry or ethnicity information  (5) 
  
 
Page Break   
 
  
Q28 How likely are you to take a direct-to-consumer genetic test for health information? 
o Extremely unlikely  (1) 
o Moderately unlikely  (2) 
o Slightly unlikely  (3) 
o Neither likely nor unlikely  (4) 
o Slightly likely  (5) 
o Moderately likely  (6) 







Q36 How likely are you to take a direct-to-consumer genetic test for health information in the 
next 30 days? 
o Extremely unlikely  (1) 
o Moderately unlikely  (2) 
o Slightly unlikely  (3) 
o Neither likely nor unlikely  (4) 
o Slightly likely  (5) 
o Moderately likely  (6) 
o Extremely likely  (7) 
  
  
Q37 How likely are you to take a direct-to-consumer genetic test for health information in the 
next 6 months? 
o Extremely unlikely  (1) 
o Moderately unlikely  (2) 
o Slightly unlikely  (3) 
o Neither likely nor unlikely  (4) 
o Slightly likely  (5) 
o Moderately likely  (6) 
o Extremely likely  (7) 
  
  
Q11 Before this survey, had you ever heard of direct-to-consumer genetic testing for health 
information? 
o Yes  (1) 
o No  (2) 
  
  
Q12 Were these uses of direct-to-consumer genetic testing for health information mainly positive 
or negative? 
o Positive (reported the usefulness or accuracy of the testing)  (1) 
o Negative (complained about result output)  (2) 







Q13 After hearing of those experiences, did you become more interested in taking a direct-to-
consumer genetic test for health information? 
o Yes  (1) 
o No  (2) 
  
End of Block: DNA Testing and Intent to Take Test 
  
Start of Block: Demographics 
  
Q26 Please respond to the following demographic questions: 
  
Q36 In which country do you currently reside? 
  
Q38 If you are a United States resident, in which state do you currently reside?  
  
Q30 What is the highest degree or level of school you have completed? If you’re currently 
enrolled in school, please indicate the highest degree you have received. 
o Some high school or less  (1) 
o High school diploma, GED, or equivalent  (2) 
o Occupational/Vocational degree  (3) 
o Some college but no degree  (4) 
o Associate’s degree (e.g. AA or AS)  (5) 
o Bachelor’s degree (e.g. BA or BS)  (6) 
o Master’s degree (e.g., MA, MS, MEd)  (7) 
o Doctorate (PhD, MD, JD)  (8) 
o Other (please specify):  (9) ________________________________________________ 
  
  
Q28 What is your ethnicity? 
o White  (1) 
o Hispanic or Latino  (2) 
o Black or African American  (3) 
o Native American and/or Alaskan Native  (4) 
o Asian  (5) 
o Pacific Islander  (6) 
o Other  (7) 




Q31 What is your annual household income? 
o Below $10,000  (1) 
o $10,000 – $20,000  (2) 
o $20,000 – $50,000  (3) 
o $50,000 – $80,000  (4) 
o $80,000 – $100,000  (5) 
o $100,000 – $125,000  (6) 
o $125,000 – $150,000  (7) 
o $150,000 – $200,000  (8) 
o $200,000 – $250,000  (9) 
o Over $250,000  (10) 
  
  
Q32 What is your marital status? 
o Single (never married)  (1) 
o Married  (2) 
o In a domestic partnership  (3) 
o Divorced  (4) 
o Widowed  (5) 
  
  
Q35 Do you have any children? 
o Yes  (1) 
o No  (2) 
o Prefer not to answer  (3) 
  
  
Q33 What is your current employment status? 
o Employed full-time (40+ hours a week)  (1) 
o Employed part-time (less than 40 hours a week)  (2) 
o Unemployed (currently looking for work)  (3) 
o Unemployed (not currently looking for work)  (4) 
o Student  (5) 
o Retired  (6) 
o Self-employed  (7) 




Q30 Please provide any additional comments on direct-to-consumer genetic testing for health 
information: 
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